



!Summary!(English)!! Trauma! is! the! leading! cause! of! death! of! children,!with! the! burden! of!mortality! related!both! to! traumatic!brain! injury! and!hemorrhagic! shock.!Despite! the! frequency!of! trauma! in! the!pediatric!population,!the!management!of!these!patients!is!often!based!on!adult!literature!due!the!sparse!amount!of! literature!in!pediatric!trauma.!The!studies!presented!below!were!intended!to!establish!current!practice,!and!prepare!for!future!prospective!studies!in!pediatric!trauma.!The!management! of! raised! intracranial! pressure! (ICP)! following! traumatic! brain! injury!(TBI)!involves!intracranial!monitoring!and!the!escalation!of!care!to!prevent!secondary!insults!to!the!brain.!Hyperosmolar!therapy!with!mannitol!(20%)!and!hypertonic!saline!(3%)!are!standard!of! care! for! the! reduction! of! ICP,! despite! little! evidence! for! their! use.! Our! retrospective,! single!center!study!aimed!to!describe!the!clinical!practice!of!hyperosmolar!therapy!in!pediatric!severe!TBI,!and!its!effect!on!ICP.!We!found!that!both!mannitol!and!hypertonic!saline!are!frequently!used!without!a!clear!indication!for!one!agent!over!another.!There!was!insufficient!power!to!confirm!an!effect! on! ICP,! and!multiple! coSinterventions! given! after! boluses! of! hyperosmolar! therapy!may!have!contributed!this!lack!of!effect.!In!order!to!prospectively!evaluate!the!effect!of!hyperosmolar!therapy!on!ICP,!a!standardized!approach!to!TBI!care!and!hyperosmolar!agents!is!necessary.!Red!blood!cell!transfusion!is!a!key!component!of!the!management!of!the!unstable!trauma!patient.! Literature! now! suggests! that! transfusion! is! associated! with! increased! mortality,! and!practices!have!shifted!toward!restrictive!transfusion!strategies!in!many!clinical!populations.!!We!sought! to! describe! the! transfusion! practices! in! pediatric! trauma! patients! based! on! a! large!previously! conducted! prospective! study! on! blood! loss! in! pediatric! intensive! care! unit! (PICU)!patients.!Compared! to!nonStrauma!patients,! trauma!patients!were!more! likely! to!be! transfused!and! transfused! early! in! their! course! of! stay.! Younger! age,! higher! PELOD! and! mechanical!ventilation!were!associated!with!receiving!a!red!blood!cell! transfusion! in! the!PICU.!Receiving!a!blood! transfusion! prior! to! PICU! admission! was! most! strongly! associated! with! receiving! a!transfusion!after!PICU!admission,!suggesting!ongoing!bleeding!in!those!transfused!early.!Future!prospective!studies!specifically!designed!for!the!above!populations!are!necessary!to!improve!medical!practice,!in!order!to!improve!the!quality!of!the!evidence!based!care!provided!to!children.!!Key!words:!Trauma,!pediatrics,!Traumatic!Brain!Injury,!Hyperosmolar!therapy,!Mannitol,!Hypertonic!saline,!Red!blood!cell!transfusion,!Anemia
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!INTRODUCTION!! Injury! is! the! primary! cause! of! morbidity! and! mortality! in! children.! According! to! the!National! Vital! Statistics! of! the! Center! for!Disease!Control,! amongst! allScause!mortality,! 32%!of!children!aged!1S9,!and!39%!of!children!over!10!years!old,!die!of!unintentional!injury!(1,!2).!The!burden!of!injury,!weighted!strongly!by!motor!vehicle!accidents,!is!primarily!caused!by!traumatic!brain!injury!(TBI)!followed!by!hemorrhagic!shock!(3,!4).! !The!treatment!of!these!morbidities!in!trauma!is!the!focus!of!this!memoire.!!
Despite! the! enormous! burden! of! trauma,! little! literature! supporting! evidenceSbased!practice! in! pediatric! trauma! management! exists.! Children! are! underrepresented! in! clinical!research,! with! practice! management! and! guidelines! that! are! often! based! on! adult! studies! or!expert!opinion.!In!addition,!adult!studies!frequently!have!much!larger!cohorts!with!consent!much!easier! to! obtain.! Pediatric! studies! are! often! smaller,! lengthier! to! conduct,! and! ethically! more!difficult! to! obtain! consent! for.! In! addition,! the! overall! burden! of! disease! is! often! perceived! as!lower! in!pediatrics.!For!the!aforementioned!reasons,!research! in!pediatrics! is!often! lacking!and!“children!are!not!small!adults”.!!
Trauma!also!has!multiple!challenges!with!regards!to!research.!Given!the!acute!nature!of!trauma,! studies! involving! trauma!patients,! and! their!management,! frequently! require! deferred!consent.! It! is! often! difficult! to! include! patients! in! randomized! controlled! trials! when! clinical!management! is! time! dependent! and! critical.! The! ethical! challenges! surrounding! consent! in!pediatric! patients! compound! the! difficulty! of! conducting! prospective! trials! in! trauma!management.!!
Despite!hurdles!in!research!on!evidenceSbased!practice,!the!creation!of!clinical!guidelines!is!widespread!in!medicine,! in!an!attempt!to!standardize!practice.!Guidelines!provide!a!common!
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framework! for! clinicians! to! adhere! to! similar! practices,! based! often! on! the! best! available!evidence!or!most!expert!opinion.!Guidelines!for!the!management!of!traumatic!brain!injury,!and!transfusion! practices,! are! published! based! on! varying! degrees! of! evidence! (5,! 6).! It! has! been!demonstrated!that!adherence!to!these!guidelines!improves!patient!outcomes,!and!therefore!their!importance!cannot!be!overstressed!(7,!8).!It!is!the!strife!for!standardized!practice!based!on!good!quality!evidence!that!will!truly!begin!to!improve!patient!outcomes.!!
The! focus!of! this!memoire! is! improving! the! literature!and!knowledge!of! trauma!care! in!the!pediatric!critical!care!population,!with!regards! to! the!management!of! the! largest!burden!of!mortality;! traumatic! brain! injury! and! hemorrhagic! shock.! The! goal! overall! is! to! improve! the!quality!of!care!we!provide,!and!practice!based!on!the!best!available!evidence.! !
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SECTION!A.!OSMOTHERAPY!IN!PEDIATRIC!TRAUMATIC!BRAIN!INJURY!!CHAPTER!1.!INTRODUCTION!TO!TRAUMATIC!BRAIN!INJURY!!1.1 TRAUMATIC!BRAIN!INJURY!AND!INTRACRANIAL!HYPERTENSION!! Traumatic!brain!injury!(TBI)!is!the!primary!cause!of!mortality!in!children!aged!6!month!into!adulthood!(1).!The!severity!of!injury!is!classified!according!to!the!Glasgow!Coma!Scale!(GCS),!a!clinical!score!on!a!scale!of!3!to!15,!designed!to!standardize!the!severity!of!neurological!impact!after! trauma.! It! has! been! subsequently!modified! to! accommodate! the! pediatric! subpopulation!(Figure!4).!The!GCS! is! inversely!proportional! to!mortality! (9).!Mild!TBI! is!defined!as!a!score!of!>13,!moderated!TBI!is!a!GCS!of!8S13,!and!severe!TBI!is!defined!as!a!GCS!<!8,!with!an!associated!mortality!between!18S65%!(10S13).!!
With! regards! to! pathophysiology,! an! initial! and!definitive! traumatic! injury! to! the! brain!occurs! during! trauma,! known! as! the! primary! hit.! The! goal! of!management! of! traumatic! brain!injury!is!to!prevent!any!secondary!injury!to!the!brain!from!occurring,!which!worsen!prognosis.!The!MonroeSKellie!hypothesis!states!that!the!cranium!is!incompressible,!with!a!fixed!volume,!and!therefore! any! increase! in! the! volume! of! one! compartment,! decreases! the! volume! of! another!compartment!(Figure!5).!In!traumatic!brain!injury,!inflammatory!vasogenic!and!cytotoxic!edema,!as!well!as!intracranial!hematomas,!result!in!raised!intracranial!pressure!(ICP),!defined!as!an!ICP!>! 20mmHg.! This! intracranial! pressure! can! therefore! result! in! compression! of! brain! tissue,!shifting! of! brain! structures,! hydrocephalus,! restrictive! blood! flow! and/or! possible! cerebral!herniation.! Prolonged! periods! of! intracranial! hypertension! have! been! associated! with! poor!neurological!outcome,!and!prompt!management!of!high!ICP!is!a!cornerstone!in!the!treatment!of!severe!TBI.!!
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The! goal! of! TBI!management! is! to! avoid! secondary! injury! to! the! brain,! preventing! any!further! cellular! damage.! This! includes! control! of! cerebral! cellular! metabolism,! temperature!control,!glucose!and!electrolyte!control,!and!adequate!perfusion!and!oxygen!delivery!to!tissues.!!1.2 INTRACRANIAL!PRESSURE!(ICP)!AND!CEREBRAL!PERFUSION!PRESSURE!(CPP)!MONITORING!!! ICP! monitoring! involves! the! neurosurgical! placement! of! an! invasive! catheter,! in! the!ventricular!or!parenchymal!portion!of!the!cranium,!to!monitor!the!ICP!(Figure!6).!An!intracranial!pressure!above!20mmHg!is!considered!high!in!both!adults!and!children.!!
! The!Cerebral! Perfusion!Pressure! (CPP)! is! defined! as! the!Mean!Arterial! Pressure! (MAP)!minus!the!Intracranial!Pressure!(ICP):!
CPP!=!MAP!–!ICP!
CPP! therefore! represents! the! net! pressure! gradient! driving! blood! flow! and! oxygen!delivery!to!brain!tissue.!AutoSregulation!of!cerebral!blood!vessels!normally!narrowly!maintains!cerebral! blood! flow! (CBF),! whereby! hypertension! causes! cerebral! vasoconstriction! to! avoid!hyperemia,!and!hypotension!causes!cerebral!vasodilation!to!avoid!ischemia,!in!order!to!maintain!constant!blood!flow!to!the!brain!within!a!set!range!of!pressures.!The!minimal! targeted!CPP!for!adults!is!50S70!mmHg,!and!minimum!of!40!mmHg!is!accepted!in!small!children!(5,!14).!!
Guidelines!for!the!management!of!severe!TBI!recommend!sedation!and!monitoring!of!ICP!for!adults!with!persistent!GCS!≤8!and!abnormal!head!CT!findings!(14).!In!pediatrics,!literature!is!poor! and! guidelines! suggest! that! clinicians! “may”!monitor! ICP! for! GCS! ≤8,!without!mention! of!head!imaging!(5).!Wide!variability!exists!in!the!rate!of!ICP!monitoring!in!pediatrics,!ranging!from!8%! to! 59%,! with! rates! being! significantly! lower! for! infants! (15S17).! In! preparation! for! the!current! study,! we! retrospectively! reviewed! reasons! why! ICP!monitoring! was! not! consistently!undertaken!in!severe!TBI!at!SainteSJustine!hospital.!The!overall!proportion!of!ICP!monitoring!for!
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severe!TBI!was!39%!from!2007!to!2014.!Primary!reasons!for!lack!of!monitoring!were!improving!GCS! (20%)! and! moribund! status! (20%),! indicating! that! in! most! cases! there! was! a! justifiable!reason!for!lack!of!monitoring!as!opposed!to!lack!of!adherence!to!guidelines![see!Appendix!1](18).!Nonetheless,! monitoring! of! a! persistently! comatose! salvageable! child! is! widely! considered!standard!practice!(7,!8,!18).!1.3 GUIDELINES!FOR!THE!MANAGEMENT!OF!SEVERE!TBI!–!HYPEROSMOLAR!THERAPY!! The!primary!goal!in!the!management!of!severe!TBI!is!to!minimize!any!secondary!impacts!on! the! brain,! known! as! second! hits,! to! optimize! the! potential! for! recovery.! After! optimizing!sedation,! neuroSmonitoring! (for! intracranial! hypertension! and! seizures),! temperature! control,!glucose! and! electrolyte! control,! hyperosmolar! therapy! is! indicated! for! the! treatment! of!persistently!elevated!ICP.!!
Hyperosmolar! therapy! (20!%!mannitol! or!3%!hypertonic! saline)! is! first! tier! therapy! in!intracranial! hypertension! management.! The! mechanisms! of! action! of! these! agents! are! the!reduction! of! blood! viscosity! and! the! reduction! of! cerebral! intracellular! fluid! by! oncotic!movement!of!water! into! the! intravascular! compartment! (19,!20).!Further!proposed! theoretical!mechanisms! are! increased! cardiac! output! and! volume! expansion! (21),! stimulation! of! atrial!natriuretic! peptide! (22),! and! restoration! of! normal! cell! volume! and! membrane! potential! for!hypertonic!saline!(23).!Hypertonic!saline!may!have!the!added!benefit!of!treating!hyponatremia,!which! can! be! deleterious! to! the! injured! brain! and! can! be! associated!with! cellular! swelling! or!cerebral! salt! wasting.! Guidelines! for! the! management! of! severe! TBI! in! adults! and! children!support!invasive!ICP!monitoring!and!hyperosmolar!therapy!for!raised!ICP!(5,!14).!There!is!some!adult! literature! suggesting! that! hypertonic! saline! is! superior! to! mannitol! for! intracranial!hypertension!in!TBI!(24S28),!however!metaSanalyses!remain!inconsistent!(29,!30).! !Despite!this!ongoing! debate,! adult! guidelines! in! 2007! from! the! Brain! Trauma! Foundation! give! a! Level! II!
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recommendation! to! mannitol,! for! the! management! of! intracranial! hypertension,! as! little!literature!was!unavailable!to!support!hypertonic!saline!use!at!the!time!(14).!!
In!Pediatrics,!the!evidence!for!hyperosmolar!therapy!is!very!limited.!Two!small!RCTs!(n=!35!and!n=18)!of!moderate!quality!demonstrated!better!control!of! ICP!and!less!need!for!further!interventions! with! hypertonic! saline! (3%)! versus! normal! saline! (31,! 32).! There! are! no!prospective! studies! involving!mannitol! for! ICP! control! in!pediatric!TBI,! despite! its!widespread!use! in! up! to! 50%!of! cases! (15).! !Hypertonic! saline! therefore! is! a! Level! II! recommendation! for!hyperosmolar!therapy!(doses!6.5ml/kg!to!10!ml/kg)!in!pediatric!TBI!guidelines!(5).!1.4 STATEMENT!OF!THE!PROBLEM!! Despite!its!use!for!raised!ICP!since!the!early!20th!century,!the!literature!to!support!the!use!of!hyperosmolar! therapy! in! ICP!reduction! is!virtually! inexistent! in!children.!There!are!no!good!quality!studies!demonstrating!superiority!of!hypertonic!saline!versus!mannitol!in!the!reduction!of! ICP,! or! on! clinical! outcomes! in! pediatrics.! Furthermore,! the! efficacy! of! both! mannitol! and!hypertonic! saline!on!reduction!of! ICP! in! children!has!not!been!clearly!established.!The!current!choice!of!agent!for!raised!ICP!in!children!is!largely!based!on!physician!and!center!preference.!As!mentioned! above,! pediatric! guidelines! recommend! hypertonic! saline! with! Level! II! evidence!based!on!little!evidence,!as!no!literature!exists!for!mannitol!(5).!!1.5 OBJECTIVE!OF!STUDY!AND!HYPOTHESIS!!! The!objective!of!our!study!was!to!describe!the!use!of!hyperosmolar!therapy!in!pediatric!TBI,! and! evaluate! the! effects! of! 20%! mannitol! and! hypertonic! saline! (3%)! on! Intracranial!Pressure.!We!hypothesized!that!mannitol!and!hypertonic!saline!are!used!with!equal! frequency,!and!may! reduce! elevated! ICP! in! the! 2! hours! post! bolus,! but! suspect! that! isolating! the! specific!effect!of!the!hyperosmolar!agent!may!be!difficult.!
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CHAPTER!2.!METHODS!2.1!STUDY!DESIGN!! We! conducted! a! retrospective! review! of! all! severe! traumatic! brain! injury! patients!admitted!to!the!Centre!Hospitalier!Universitaire!(CHU)!SainteSJustine!in!the!last!7!years,!in!order!to! describe! practice! and! use! of! hyperosmolar! therapy! in! pediatric! TBI.! The! study! is! an!observational! descriptive! study! with! no! intervention.! Given! the! nature! of! the! study! design,!patient!consent!was!not!necessary!and!the!institutions’!ethics!review!board!approved!the!study.!2.2!SETTING!!! The!CHU!SainteSJustine! is!a! tertiary!pediatric!and!maternal!care!center,!and! trauma!center,!located! in!Montreal,!Quebec,! Canada.!The!pediatric! intensive! care!unit! of! SainteSJustine! admits!approximately! 1000! patients! per! year,! and! approximately! 10! severe! TBI! patients.! Given! the!geography! of! the! province,! trauma! patients! can! be! transported! from! as! far! as! 7000! km! away,!requiring!air!transport!and!multiple!stops!at!prior!health!care!facilities.!At!the!time!of!the!study,!there!was!no!specific!protocol!for!the!management!of!severe!TBI,!and!the!treating!medical!team!guided!therapy.!2.3!POPULATION!! All! consecutive! patients! admitted! between! April! 2007! and! April! 2014! to! the! pediatric!intensive! care! unit! (PICU)! of! CHU! SainteSJustine,! were! screened.! Eligible! patients! were! age! 1!month!to!18!years!old,!and!had!severe!TBI!as!defined!by!GCS!≤!8!on!admission!to!the!emergency!department! of! SainteSJustine.! Specific! inclusion! criteria! were! invasive! ICP! monitoring,! and!administration! of! a! hyperosmolar! agent! (20%! mannitol! or! 3%! hypertonic! saline)! thereafter,!within!48!hours!of!PICU!admission.!There!were!no!specific!exclusion!criteria.!2.4!INTERVENTION!
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! In! order! to! study! the! objective! in! this! observational! study,! we! evaluated! boluses! of!osmotherapy!as!events.!Each!bolus!of!mannitol!20%!or!3%!hypertonic!saline!was!recorded!in!the!first! 48! hours! after! PICU! admission.! Time! of! bolus,! dose,! volume! and! concentration! were! all!recorded,!to!an!arbitrary!maximum!of!10!boluses!per!patient.!In!addition!to!data!on!the!bolus!of!osmotherapy,! vital! signs! including!heart! rate,! blood!pressure! (BP),! Intracranial!Pressure! (ICP),!and!Cerebral!Perfusion!Pressure!(CPP)!were!recorded!at! the! time!of! the!bolus!and! for! the! four!hours! following! the!bolus.! ICP!and!CPP!were!recorded!up! to!every!15!minutes!when!available.!Temperature!and!diuresis!were!recorded!every!hour.!All!blood!gases,!serum!sodium,!osmolarity,!and! hemoglobin! values!were! recorded! for! the! 48! hours! post! admission.! Infusions! of! sedation!were!recorded,!along!with!changes!in!infusion!rates.!
2.4.1!COSINTERVENTIONS!! CoSinterventions!were!defined!as!any!therapy!that!could!have!an!impact!of!the!reduction!of!intracranial!pressure!in!the!4!hours!following!a!bolus!of!hyperosmolar!therapy.!For!the!purpose!of! this! study,! coSinterventions! included! another! hyperosmolar! agent! (mannitol! 20%! or! 3%!hypertonic! saline),! a! bolus! of! sedation! with! a! barbiturate! or! propofol,! a! hypertonic! saline!infusion,!or!a!decompressive!craniectomy.!Intermittent!boluses!of!fentanyl!or!morphine!were!not!included! in! the!coSinterventions!as! they!were! too! frequent! in!nature,!and! their!effect!would!be!temporally!difficult! to! assess.!Any! repeat!bolus!of!hyperosmolar! therapy!within!4!hours!of! the!last!bolus!was!recorded,!along!with!its!dose!and!concentration.!!2.5!OUTCOME!MEASURES!2.5.1!PRIMARY!OUTCOME!!
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The! primary! outcome! was! the! reduction! in! ICP,! as! measured! by! mean! change! in!intracranial!pressure!after!the!hyperosmolar!bolus.!PreSbolus!ICP!values!were!considered!as!time!of!bolus!administration!or!within!15!minutes!prior,!and!post!bolus!values!were!assessed!on!the!hour,!for!the!following!4!hours.!When!more!frequent!measures!were!present,!hourly!mean!values!were!calculated.!!
2.5.2!SECONDARY!OUTCOME!! Secondary! outcomes! measured! included! the! effect! of! hyperosmolar! therapy! on! mean!arterial!blood!pressure!(MAP),!cerebral!perfusion!pressure!(CPP),!and!serum!sodium.!In!addition,!the! number! of! coSinterventions! postSbolus! in! each! group! was! a! secondary! outcome,! as! a!surrogate!for!therapy!failure.!!2.6!SAMPLE!SIZE!CALCULATION!! Sample! size! calculation! for! this! retrospective! review! was! performed! using! GSPower.! We!calculated!the!number!of!boluses!of!hyperosmolar!therapy!needed!in!each!group!(mannitol!and!hypertonic! saline)! in!order! to!detect! an! intraSgroup!mean! change! in! ICP!of!15%!post!bolus.! In!order!to!detect!a!mean!difference!of!15%,!with!a!power!of!80%!and!a!bilateral!alpha!of!0.05,!a!sample!size!of!15!observations! in!each!group!was!needed,!with!a! calculated!effect! size!of!1.06.!The! possible! lack! of! independence! of! events! was! not! taken! into! consideration! for! this! study.!!Archive!review!indicated!approximately!10S12!severe!TBI!admissions!to!the!PICU!annually.!!We!elected! to! review! the! previous! 5! years,! considering! most! patients! will! have! received! both!mannitol! and! hypertonic! saline.! Multiple! patients! not! meeting! inclusions,! as! well! as! many!patients!not!receiving!mannitol,!led!to!the!prolonging!of!an!additional!2!years!of!review!to!gain!in!sample! size! and! power.!We! therefore! retrospectively! reviewed! the! last! 7! years! of! severe! TBI!admissions.!
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2.7!DATA!COLLECTION!AND!ANALYSIS!!! Demographic! data! including! time! and!mechanism! of! injury,! head! imaging,! and! referral!from! another! center,! were! documented! from! charts.! We! described! the! use! of! hyperosmolar!agents,!20%!mannitol!or!3%!hypertonic!saline!bolus!(or!infusion),!to!a!maximum!of!10!boluses!per!patient! in!48!hours.! ! Several!boluses!were!administered!without!elevated! ICP,! therefore! to!maximize!potential! for! finding!an!effect,! the! impact!on!ICP!and!CPP!was!assessed!following!the!first!2!boluses!received!only!for!an!ICP!>!20!mmHg.!The!measured!change!in!ICP!and!CPP!were!recorded!hourly!for!the!4!hours!post!bolus.!Only!the!first!two!boluses!were!analyzed!to!minimize!background!noise!and!effect!of!coSinterventions!on!ICP,!which!increased!consistently!over!time!in!the!PICU.!!All! data! and! vital! signs! were! collected! in! paper! charts! until! January! 2013,! and! with!electronic! charting! thereafter.! ! Missing! values! at! 4th! hour! (n=3! values)! for! ICP! and! CCP! were!treated! by! unit! imputation.! CoSinterventions! to! control! ICP! (additional! hyperosmolar! agent,!propofol,! barbiturate! bolus,! decompressive! craniectomy,! and! 3%!hypertonic! saline! continuous!infusion),! and! change! in! serum! sodium! were! also! documented.! PreSbolus! sodium! value! was!defined!as! the! last! value!obtained!within!6!hours!prior! to!bolus,! and!postSbolus! value!was! the!first!serum!sodium!between!1!and!6!h!postSbolus.!2.8!CHOICE!OF!STATISTICAL!METHODS!! Descriptive! data! are! reported! in!median! (IQR!=! interquartile! range),!mean! (±! standard!deviation),! and!n! (%)!where!appropriate.!Using!SPSS,! repeated!measures!ANOVA!was!used! for!analysis! of! trending! continuous! variables! (i.e.! mean! ICP! and! CPP)! with! Bonferonni! tests! for!comparison! of! means! when! significant.! NonSparametric! Mann! Whitney! test! was! used! for!comparison! of! baseline! values.! Paired! tStest! was! used! for! comparison! of! preS! and! postS!quantitative!values!where!n!was!sufficient.!A!pSvalue!of!0.05!was!used!for!statistical!significance.!
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There!was!an! insufficient!sample!size! to!compare! the!change! in! ICP!between!treatment!groups!(mannitol!versus!hypertonic!saline),!however!this!was!not!the!objective!of!the!study.!2.9!AUTHOR!CONTRIBUTIONS!! !! Nadia! Roumeliotis! performed! all! the! data! collection,! aided! in! database! design,!contributed! to! statistical! analysis,! and! drafted! manuscript.! Christian! Dong! performed! data!extraction,!and!aided!with!statistical!analysis.!Geraldine!Pettersen!and!Louis!Crevier!contributed!to!study!design,!medical!and!surgical!content,!and!correction!of!manuscript.!Guillaume!Emeriaud!designed!study,!aided! in!database!design,!wrote! initial!protocol,!oversaw!statistical!analysis,!as!well!as!corrections!of!final!manuscript.!All!authors!approved!the!final!version!of!the!article,!and!none!have!conflicts!of!interest.!! !
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Design:! A! retrospective! review! of! patients!with! severe! TBI! admitted! to! the! pediatric! intensive!care!unit!(PICU)!was!conducted.!Inclusion!criteria!were!ICP!monitoring!and!administration!of!a!hyperosmolar!agent!(20%!mannitol!or!3%!hypertonic!saline)!within!48h!of!PICU!admission;!for!which! dose! and! timing! were! recorded.! For! the! first! 2! boluses! received! for! increased! ICP!(>20mmHg),! the! impact! on! ICP! and! CPP! was! assessed! during! the! following! 4! hours,! using!repeated! measures! ANOVA.! CoSinterventions! to! control! ICP! (additional! hyperosmolar! agent,!propofol!or!barbiturate!bolus),!and!serum!sodium!were!also!documented.!!
Setting:!A!tertiary!care!pediatric!hospital!center.!
Patients:!Children!aged!1!month!to!18!years,!with!severe!traumatic!brain!injury!(Glasgow!Coma!Score!≤!8),!and!intracranial!pressure!(ICP)!monitor.!!
Results:!SixtySfour!patients!were!eligible,!of!which!16!met!inclusion!criteria.!The!main!reason!for!exclusion!was!lack!of!ICP!monitor.!Average!age!was!11!years!(SD±!4)!and!median!Glasgow!Coma!Score!was!6!(range!4S7).!One!hundred!and!seven!boluses!were!identified,!and!70%!percent![95%!CI! 64.0S74.3]! of! boluses! were! 3%! hypertonic! saline,! with! no! identified! baseline! difference!associated!with!this!initial!choice.!Both!mannitol!and!hypertonic!saline!were!followed!by!a!nonSsignificant! decrease! in! ICP! (mannitol,! p=0.055! and! hypertonic! saline,! p=0.096).! There! was! no!significant!change!in!CPP!post!bolus.!A!coSintervention!occurred!in!69%!of!patients!within!the!4h!post!hyperosmolar!agent,!and!8!patients!received!continuous!3%!saline.!
Conclusion:! In!pediatric!TBI!with! intracranial!hypertension,!mannitol!and!3%!hypertonic!saline!are!commonly!used,!but!dose!and!therapeutic!threshold!for!use!vary!without!clear!indications!for!
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one! versus! another.! Controlled! trials! are! warranted,! but! several! barriers! were! identified,!including!high!exclusion!rate,!multiple!coSinterventions,!and!care!variability.!
Keywords!:! Traumatic! Brain! Injury,! Pediatric,! Hyperosmolar! Therapy,! Mannitol,! ! 3%!Hypertonic!Saline,!Intracranial!Hypertension!
% %
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INTRODUCTION%! Traumatic!brain! injury! (TBI)! is! the!number!one! cause!of!death!and!morbidity! amongst!children!aged!1!to!16!years!(1).!Severe!TBI,!defined!as!a!Glasgow!coma!score!(GCS)!≤!8,!typically!requires! aggressive! management! due! to! poor! prognosis! and! high! associated! mortality.!Intracranial!hypertension! is!associated!with!poor!outcome!and!increased!mortality!(2).!Control!of!Intracranial!Pressure!(ICP)!and!maintenance!of!Cerebral!Perfusion!Pressure!(CPP,!defined!as!mean!arterial!pressure!–!ICP)!are!cornerstones!in!the!management!of!severe!TBI,!with!targets!of!<20mmHg!and!>!40mmHg!(>!50!mmHg!in!older!adolescents)!respectively!(3).!!Hyperosmolar! therapy! (20!%!mannitol! or!3%!hypertonic! saline)! is! first! tier! therapy! in!intracranial!hypertension!management.!The!hypothesized!mechanisms!of!action!of!these!agents!are! the!reduction!of!blood!viscosity,!and!the!reduction!of!cerebral! intracellular! fluid!by!oncotic!movement!of!water!into!the!intravascular!compartment!(4,!5).!Guidelines!for!the!management!of!severe!TBI!in!adults!and!children!(6),!support!invasive!ICP!monitoring!and!hyperosmolar!therapy!for!raised!ICP.!Despite!its!use!for!raised!ICP!since!the!early!20th!century,!the!literature!to!support!hyperosmolar! therapy! in! ICP! reduction! is! virtually! nonSexistent! in! children! (3).! There! is! some!adult! literature! suggesting! that! hypertonic! saline! is! superior! to! mannitol! for! intracranial!hypertension! in! TBI,! however! metaSanalyses! remain! inconsistent! (7S13).! Given! this! ongoing!debate,! adult! guidelines!do!not! suggest! one! agent! over! another! (6).! In!pediatrics,! there! are!no!studies!demonstrating!superiority!of!hypertonic!saline!versus!mannitol! in! the!reduction!of! ICP,!or! on! clinical! outcomes.! Furthermore,! the! efficacy! of! both! mannitol! and! hypertonic! saline! on!reduction!of!ICP!in!children!has!never!been!established.!Hypertonic!Saline!(3%)!has!been!shown!to! decrease! coSinterventions! for! ICP! in! 2! small! randomized! trials! when! compared! to! Ringer`s!Lactate!and!normal!saline!(14,!15).!The!current!choice!of!agent!for!raised!ICP!in!children!remains!hypertonic! saline! according! to! guidelines! (level! II)! as! no! article! on! the! effect! of!mannitol!met!guideline! inclusions! (3).! Use! of! hypertonic! saline! and! mannitol! remain! to! some! extent,! both!
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center!and!physician!dependent.!Indeed,!studies!have!demonstrated!a!large!variability!in!practice!with! regards! to! hyperosmolar! therapy,! dependent!mostly! on! age! and! treating! center! (16,! 17).!Pediatric!TBI!guidelines!have!therefore!stressed!the!need!for!further!research!on!the!efficacy!of!hyperosmolar! therapy.! The! specific! objective! of! our! study! was! to! describe! the! use! of!hyperosmolar! therapy! for! severe! TBI,! and! examine! the! effect! of! 20%! mannitol! and! 3%!hypertonic!saline!on!ICP!and!CPP!when!administered!for!intracranial!hypertension.!The!study!is!an!essential! first! step! to!assess! the! feasibility,!and!prepare! for!a! randomized!controlled! trial!of!hyperosmolar!therapy!for!pediatric!TBI.!
MATERIALS%AND%METHODS%!! We!conducted!a!retrospective!review!of!all!TBI!patients!admitted!between!April!2007!and!April! 2014! to! the! pediatric! intensive! care! unit! (PICU)! of! CHU! SainteSJustine,! a! pediatric! and!maternal!tertiary!care!center,!and!a!trauma!center.!The!Institutional!Review!Board!approved!the!chart!review!for!this!study.!Eligible!patients!were!age!1!month!to!18!years!old,!had!severe!TBI!as!defined!by!GCS!≤!8!on!admission.! Specific! inclusion! criteria!were! invasive! ICP!monitoring,! and!administration!of!a!hyperosmolar!agent!thereafter,!within!48h!of!PICU!admission.!! Demographic! data,! including! time! and!mechanism!of! injury,! imaging,! and! referral! from!another! center! were! documented! from! charts.!We! described! the! use! of! hyperosmolar! agents,!20%! mannitol! or! 3%! hypertonic! saline! bolus! (or! infusion),! to! an! arbitrary! maximum! of! 10!boluses!per!patient!in!48!hours.!The!standard!solution!for!hypertonic!saline!in!our!center!is!3%.!No!standardized!TBI!protocol!was!in!place!for!guidance!of!hyperosmolar!therapy!use.!The!impact!on!ICP!and!CPP!was!assessed!for!a!4!hour!period!following!the!first!2!boluses!received!for!an!ICP!>!20!mmHg.!Further!boluses!were!not!evaluated,!given!potential!decreasing!efficacy,!unbalanced!weighing! of! patients,! multiple! other! coSinterventions! to! control! ICP,! and! overall! background!noise! with! concomitant! therapy.! All! data! and! vital! signs! were! collected! in! paper! charts! until!
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January!2013,!and!with!electronic!charting! thereafter.! !Missing!values!at!4th!hour!(n=3)! for! ICP!and!CCP!were!treated!by!unit!imputation,!i.e.!extrapolated!from!3rd!hour!value.!CoSinterventions!to! control! ICP! (additional! hyperosmolar! agent,! propofol,! barbiturate! bolus,! decompressive!craniotomy,!and!3%!hypertonic!saline!continuous! infusion),!and!change! in!serum!sodium!were!also!documented.!PreSbolus!sodium!value!was!defined!as!the!last!value!obtained!within!6!hours!prior!to!bolus,!and!postSbolus!value!was!the!first!serum!sodium!between!1!and!6!h!postSbolus.!
! Descriptive! data! are! reported! in!median! (IQR!=! interquartile! range),!mean! (±! standard!deviation),! and!n! (%)!where!appropriate.!Using!SPSS,! repeated!measures!ANOVA!was!used! for!analysis!of!trending!mean!ICP!and!CPP,!and!post!bolus,!with!Bonferonni!tests!for!comparison!of!means!when!significant.!NonSparametric!Mann!Whitney!test!was!used!for!comparison!of!baseline!values.! Paired! tStest! was! used! for! comparison! of! preS! post! quantitative! values! where! n! was!sufficient.!A!pSvalue!of!0.05!was!used!for!statistical!significance.!!
RESULTS% %!! SixtySfour!patients!were!eligible,!of!which!16!met!inclusion!criteria!and!were!included!in!the!analysis!(Figure!1).!A!high!proportion!of!patients!did!not!undergo!ICP!monitoring,!either!due!to! improving! GCS! or! moribund! status! (18).! Patient! demographics! and! injury! details! are!presented!in!Table!1.!All!ICP!monitors!were!intraSparenchymal,!except!for!two!extraSventricular!drains!used!to!evacuate!cerebrospinal!fluid.!!
Use%of%Hyperosmolar%Agents!! A!total!of!107!hyperosmolar!boluses!were!recorded,!with!a!median!number!of!6.5!boluses!per!patient!(IQR!4.5S10,!range!1S10).!Seventy!percent!of!boluses!were!3%!hypertonic!saline!and!30%!were!mannitol!(Figure!2).!All!patients!received!3%!saline,!while!3!never!received!mannitol.!Given!persistently!high!ICP,!3!patients!had!standing!orders!to!alternate!boluses!of!mannitol!with!3%!saline!every!3!or!4!hours.!No! identified!patient!baseline!characteristic!was!associated!with!
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the!initial!choice!of!mannitol!or!3%!saline!(Table!2),!particularly!with!no!statistical!difference!in!age,! GCS,! Mean! Arterial! Pressure! (MAP),! or! ICP.! PreSbolus! serum! sodium! was! also! similar! in!patients!who! received! 3%! hypertonic! saline! as! first! bolus! (141!mOsm/L! ±! 4)! as! compared! to!mannitol!(139!mOsm/L!±!1).!!
Average!doses!of!mannitol!and!3%!hypertonic!saline!given!were!0.6!g/kg!±!0.2!and!1.8!ml/kg! ±! 0.7,! respectively.! Given! the! osmolarity! of! mannitol! (1100! mOsm/L)! and! hypertonic!saline!(1027!mOsm/L),! the!average!relative!osmolar! load! for!mannitol! (3.5!Osm/kg!±!0.9)!was!therefore! almost! twice! that! of! 3%! saline! (1.8! mOsm/kg! ±! 0.7).! In! addition! to! hyperosmolar!boluses,!8!(50%)!patients!received!a!continuous!infusion!of!hypertonic!saline!during!the!first!48h!of!admission.!Initial!3%!saline!infusion!rate!was!0.5!ml/kg/h!(IQR!0.5S0.7)!initiated!at!a!median!of!10!hours!(IQR!9S13)!after!admission.!
Analysis%of%first%two%hyperosmolar%boluses%received%! For! the! first! two!boluses!of!hyperosmolar! therapy! received! for! raised! ICP! (>20mmHg),!both!mannitol!and!hypertonic!saline!were!followed!by!a!decrease!in!ICP!in!the!following!4Shour!period,! however! this! did! not! achieve! statistical! significance! (mannitol! n=8,! p=0.055! and!hypertonic!saline!n=14,!p=0.096)(Figure!3a).!There!was!no!change!in!CPP!post!bolus!(mannitol!p=0.8!and!hypertonic!saline!p=0.5)!(Figure!3b).!Serum!sodium!did!not!significantly!change!post!mannitol! or! hypertonic! saline! (Sodium! pre=140±2! vs.! post=139±2! and! pre=142±7! vs.!post=142±6,!p=0.94!and!p=!1.0!respectively).!!!
CoZinterventions%
% Eleven! patients! (69%)! received! a! coSintervention! to! decrease! ICP! within! 4h! post! first!hyperosmolar! agent.! Ten! (62%)! patients! received! another! bolus! of! a! hyperosmolar! agent!(mannitol!or!hypertonic!saline)!within!a!median!time!of!40!min!(IQR!26S79),!2!patients!received!
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a! concomitant!3%!saline! infusion! (after!140!min!and!230!min),! 2!patients! received!a!propofol!infusion!(after!20min!and!5!min)!and!2!others!received!a!thiopental!infusion!(after!1!min!and!120!min).!!! !DISCUSSION!! This!study!describes!the!use!and!effect!of!hyperosmolar!therapy,!with!mannitol!and!3%!saline,! on! ICP! in! pediatric! TBI.! Our! findings! illustrate! the! wide! variability! in! practice! and!administration! of! these! agents,! and! the! trend! toward! a! reduction! in! ICP! associated!with! their!administration,! although! this! did! not! achieve! statistical! significance.! The! small! sample! size!highlights! the! difficulty! in! conducting! research! on!pediatric! TBI! patients.! Severe!TBI! requiring!ICP!monitor! and!hyperosmolar! therapy! remains! relatively!uncommon,! and!multiple! exclusions!make! large! sample! sizes! lengthy! to! achieve.! As! previously! published! by! our! group,! there! are!many!patients!who!do!not!undergo!ICP!monitoring!given!extremely!poor!prognosis,!or!improving!clinical!neurological!status!(18).! !Nonetheless,! this!study!provides!new!insights!with!regards!to!hyperosmolar!therapy!practices!and!the!preparation!for!futures!studies.!!
We!found!variability!in!the!choice!of!hyperosmolar!agent!used,!both!initially!and!over!the!first!48h.!In!addition,!both!dosage!and!threshold!ICP!for!use!varied!between!treating!physicians.!Several! patients! received! mannitol! or! 3%! saline! without! having! clearly! elevated! ICP! (<20!mmHg),!while!others!received!agents!in!close!succession!for!refractory!intracranial!hypertension.!Bennett! et! al.! have! also! reported!wide! variability! in! a! retrospective! database! analysis! of! over!6000! pediatric! TBI! patients,! with! 33%! of! patients! receiving! hypertonic! saline,! 40%! receiving!mannitol! and! 28%! receiving! both! (19).! The! use! of! hyperosmolar! agents! was! associated! with!older!age,!more!severe!injury,!intracranial!hemorrhage!and!use!of!ICP!monitor.!They!also!noted!a!decrease! in! the! use! of! mannitol! after! publication! of! the! 2003! guidelines,! and! higher! use! of!
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hypertonic! saline! in! cases! of! hyponatremia! (20).! A! 2013! international! survey! of! 34! centers!revealed! that!despite!similar! ICP!and!CPP!goals,!medical!management!of! raised! ICP!varies,!and!although!90%!of! centers! use! hyperosmolar! therapy,! concentrations! of! hypertonic! saline! range!from!3%!to!23%!and!certain!centers!never!use!either!agent!(18).!In!the!present!study,!there!did!not!appear!to!be!a!specific!factor!associated!with!the!choice!of!mannitol!or!3%!saline!for!choice!of!agent,!dose!and!osmolar!load,!threshold!ICP,!or!use!of!continuous!saline!infusion.!Contrary!to!our!assumptions,!initial!serum!sodium!level!did!not!seem!to!dictate!the!choice!of!first!hyperosmolar!agent;!although!hyponatremia,!which!may!predispose!to!choosing!3%!saline,!was!not!observed!in!our!series.!
Both!3%!hypertonic!saline!and!mannitol!were!associated!with!decreases!in!ICP,!although!this!did!not!achieve!statistical!significance.!Importantly,!causality!is!impossible!to!establish!given!the!lack!of!a!controlled!environment!and!retrospective!nature!of!the!study.!The!observed!trend!could!be!the!natural!spontaneous!evolution!of!the!ICP,!the!effect!of!the!hyperosmolar!agents,!or!the! consequence!of!multiple!other! factors.! ! Several! adult! studies!have!evaluated!hyperosmolar!agents! on! ICP! in! TBI,! but! doses! of! both! agents! and! results! vary.! Vialet! et! al.! compared!isovolumetric! doses! (2ml/kg)! of! 7.5! %! saline! and! 20! %! mannitol! on! ICP! and! found! that!hypertonic!saline!with!higher!osmolar!load!was!more!effective!in!controlling!refractory!ICP!(9).!Harutjunyan!et! al.! found! similar! results! in! a! randomized! trial! comparing!7,2%!saline!and!15%!mannitol! (8).! When! using! equiosmolar! dosing,! Battison! et! al.! (250! mOsm/dose! mannitol! and!7,5%! saline)! and! Cottenceau! et! al.! (20%! mannitol! at! 4ml/kg,! 15%! saline! at! 2ml/kg)! also!concluded! that! hypertonic! saline! had! a! greater! effect! on! ICP! (12,! 13).! This! difference!was! not!reproduced!however,!by!a!randomized!trial!by!Francony!et!al.!and!Sakelaridis!et!al.!who!found!no!difference!between!mannitol!and!hypertonic!saline!on!ICP!(10,!21).!There!are!few!studies!on!the!effect!of!hypertonic!saline!or!mannitol!on!ICP!in!pediatrics,!and!none!has!compared!both!agents.!
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A! recent! prospective! study! by! Stein! et! al.,! and! the! only! other! study! evaluating! hyperosmolar!therapy!in!pediatric!TBI,!demonstrated!a!decrease!in!ICP!after!hypertonic!saline!after!correcting!for! cofactors.! There!was! insufficient! data! to! conclude! on!mannitol’s! effect! on! ICP! (22).! In! our!study,!the!effect!of!mannitol!and!hypertonic!saline!were!not!compared!to!one!another,!given!the!difference!in!osmotic!load,!small!sample!size!and!heterogeneity!of!both!groups,!which!made!them!poorly! comparable.! The! relatively! higher! osmolar! load! of! mannitol! compared! to! hypertonic!saline! in! our! study! (3.5! versus! 1.8mOsm/kg)! may! explain! the! lack! of! statistically! significant!decrease!in!ICP!after!both!agents.!Again,!their!effect!on!ICP!has!never!been!clearly!demonstrated!in!pediatrics.!!!
Serum! sodium! was! surprisingly! unchanged! after! hyperosmolar! boluses.! This! is! in!contrast! to! the! literature,!which!has!consistently!shown!a!significant! increase! in!serum!sodium!after!hypertonic!saline!(8,!9,!13,!23).!It!may!be!that!the!dose!of!hypertonic!saline!was!generally!quite! low!(average!1.8!ml/kg)!and!dose!and!concentration! in! the!cited! literature! is!often!much!higher!(often!2ml/kg!of!7.5!%!saline!or!5S10!ml/kg!of!3%!saline)!(3).!!
! There! are! other! limitations! to! the! study,! especially! given! its! retrospective! nature.! We!were! unable! to! control! for! hyperosmolar! agents! received! prior! to! ICP! monitor! placement,! in!emergency!department!or!operating!room,!and!their!effect!on!osmolarity,! intravascular!volume!and!viscosity,!or!ICP.!CoSinterventions!contributing!to!the!reduction!in!ICP!were!also!difficult!to!account!for,!given!multiple!concomitant!therapeutic!interventions.!All!these!variables!could!have!diluted!the!expected!effect!of!the!agents.!Although!we!examined!the!administration!of!additional!hyperosmolar!boluses,!barbiturates,!and!propofol,!we!did!not!take!into!account!small!boluses!of!sedation! (fentanyl,! morphine,! etc..),! opioid! and! benzodiazepine! sedative! infusions! and!hyperventilation,! as! these! were! too! frequent! and/or! transient! in! occurrence.! All! of! the!aforementioned! agents! however,! potentially! contribute! to! ICP! reduction! and! therefore! results!
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should! be! cautiously! interpreted.! In! an! attempt! to! limit! the! multiple! coSinterventions! and!confounders!on!ICP!control,!we!only!evaluated!the!first!2!boluses!given!for!ICP!>!20mmHg.!!
! Future!prospective!controlled!studies!are!necessary!to!establish!the!effectiveness!of!both!mannitol! and! hypertonic! saline! in! pediatric! TBI.! Prior! to! initiating! prospective! trials,! issues!regarding! feasibility!must!be!addressed.!Multiple!centers!will!be!needed! to!gain!enough!power!for! accurate! conclusion.! Both! interS! and! intraShospital! variability! in! practice! will! require! a!standard!protocol!for!ICP!management.!Specific!criteria!for!invasive!ICP!monitoring!are!needed!along!with!continuous!electronic!data!collection,! invasive!arterial!monitoring,! temperature!and!position!control,!standardized!ventilation,!protocolized!sedation,!followed!by!an!escalation!with!criteria! for! administration! of! a! hyperosmolar! agent.! The! hyperosmolar! agents! should! be! a!standard! dose! per! weight,! and! time! of! administration.! Another! difficulty! in! the! feasibility! of!randomized!controlled! trials! is! rapid! randomization!and!potential!deferred!consent!needed,! as!agents!are!often!rapidly!administered!after!ICP!monitoring.!!
CONCLUSION!! The! study! is! an! important! first! step! in! the! knowledge! of! hyperosmolar! therapy! for!pediatric! TBI.! It! is! critical! to! understand! our! current! practices,! expected! outcomes,! and! coSinterventions,!in!order!to!prepare!for!future!controlled!studies.!Several!barriers!were!identified.!In!particular,!we!confirmed!the!difficulty!in!obtaining!a!large!sample!size!due!to!the!low!incidence!of!severe!TBI!and!the!high!rate!of!exclusion!criteria.!As!seen!in!the!other!pediatric!study!(22),!we!observed! a! very! high! number! of! coSinterventions! to! decrease! ICP,! which! are! potential!confounding!factors.!Moreover,!the!practice!variability!was!evident!and!should!be!addressed.!In!order!to!overcome!those!difficulties,!a!multiScenter!study!would!likely!be!required,!with!a!stepSwise!standard!sedation!protocol!for!escalation!in!therapy,!and!defined!criteria!for!administering!
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an! additional! hyperosmolar! bolus.! Providing! equiSosmolar! loads! of! both! mannitol! and! 3%!hypertonic!saline!would!also!be!necessary!to!compare!their!effects!on!ICP!reduction.!!
Despite! widespread! use! of!mannitol! and! 3%! hypertonic! saline! for! the!management! of!raised!ICP!in!TBI,!there!is!no!good!evidence!for!their!efficiency!and!indications!in!pediatrics.!Good!quality! prospective! data! is! crucially! needed! to! support! the! recommendation! of! their! use,! and!evidence!based!practice!in!neurocritical!care!in!pediatric!TBI.!
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Table! 2.! Baseline! characteristics! of! patients! receiving!mannitol! or! hypertonic! saline! as! first! 2!boluses!
% Mannitol%% 3%%Saline%% p%value%
BOLUS%1% N=3% N=13% !Age!(years)! 11!(9S13)! 13!(10S15)! 0.7!Glasgow!Coma!Score! 4!(4S4.5)! 6!(6S7)! 0.15!Intracranial!Pressure!(mmHG)! 21!(17S25)! 23!(19S28)! 0.7!Mean!Blood!Pressure!(mmHG)! 76!(75S77)! 84!(79S86)! 0.2!
BOLUS%1%&%2! N=9! N=21! !Intracranial!Pressure!(mmHG)! 27!(22S32)! 20!(19S26)! 0.1!Mean!Blood!Pressure!(mmHG)! 78!(76S90)! 82!(72S86)! 0.8!!Results!presented!in!Median!(IQR:!Interquartile!range!25S75!percentile)!Mann!Whitney!U!Test!used!for!independent!means!!!! !
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SECTION!B.!TRANSFUSION!PRACTICES!IN!PEDIATRIC!TRAUMA!!CHAPTER!4.!INTRODUCTION!!4.1!ANEMIA!IN!PEDIATRIC!CRITICAL!CARE!! Anemia,!defined!as! a! reduced!amount!of! red!blood! cells! or!hemoglobin! (Hb)! for! age,! is!very!common!both!in!adult!and!pediatric!critical!care!(33,!34).!Reasons!for!this!include!disease!state,! bleeding,! procedures,! frequent! blood! sampling,! inflammation,! chronic! illness! and!myelosuppression,!amongst!others.!Red!blood!cells,!and!more!specifically!the!hemoglobin!within!them,! are! critical! for! the! transport! of! oxygen! in! blood! to! the! tissues,! and! ensuring! adequate!oxygen! content! of! blood! (CaO2).! Oxygen! delivery! (DO2)! to! tissues! is! dependent! on! arterial!oxygen!content!(CaO2),!a!factor!of!hemoglobin!and!oxygen!saturation!(SaO2),!and!cardiac!output!(CO),!a!factor!heart!rate!and!ventricular!stroke!volume.!The!formula!for!delivery!of!oxygen!is:!
DO2!=!CaO2!x!CO!=![(SaO2!x!Hb!x!1.34)!+!0.003!x!PaO2]!x![HR!x!SV]!
In! normal! physiological! states,! the! delivery! of! oxygen! to! tissues! is! far! superior! to! the!demand.! However! in! disease! states,! anemia,! decreased! oxygen! saturation,! reduced! cardiac!output!and!increased!metabolic!demand!can!all!contribute!to!reduced!oxygen!delivery!to!tissues!and! cells.!When! the! delivery! of! oxygen! is! insufficient! to!meet! oxygen! demand,! tissue! hypoxia!results!and!cells!move!from!aerobic!metabolism!to!anaerobic!metabolism.!
There! is!no! fixed! threshold! for! transfusion!of! red!blood!cells! in! critical! care.!The!AABB!American! Academy! of! Blood! Bankers! (AABB)! and! Society! of! Critical! Care! Medicine! (SCCM)!consensus! recommends! that! transfusion! must! be! given! for! a! Hb! <! 5g/dL,! and! should! be!considered! if! the!Hb! is!<7g/dL,!but! the! level!of!evidence!behind!these!recommendations! is!not!optimal!in!trauma!patients!is!li(6).!!
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4.2!HARMFUL!EFFECTS!OF!BLOOD!TRANSFUSIONS!! Over! the! past! two! decades! the! concept! of! «!permissive! anemia!»! has! become! standard!practice,! as! the! harmful! effects! of! red! blood! cell! transfusions! have! more! clearly! been!demonstrated.! Plasma! rich! blood! products! which! include! red! blood! cell! transfusions! contain!inflammatory!mediators! including! cytokines,! complement! activators,! and! oxygen! free! radicals!that! may! initiate! or! enhance! an! inflammatory! process.! Complications! of! transfusions! include!febrile!reactions,!volume!overload,!transfusion!associated!lung!injury!(TRALI),!allergic!reactions,!hemolysis,!coagulopathy!and!multiSorgan!failure!(MOF)!(35,!36).!!In!addition,!the!potential!risk!of!infection! transmitted! through! transfusion! has! been! raised,! although! safety! profiles! of! blood!products!have!greatly! increased!and! these! infections!are!now!virtually! inexistent! in!developed!countries.! Complications! related! to! blood! storage! also! raise! concern;! including! hyperkalemia,!hemolysis,!and!hypocalcaemia!from!citrate!toxicity.!!
In!adult! critical! care,! liberal! transfusion!strategy!of! red!blood!cells! (<9!g/dL!vs!7!g/dL)!has!been!associated!with!an!increased!rate!of!cardiac!events,!pulmonary!edema!and!myocardial!infarction! (37).! In! the!PICU,!patients!having! received! red!blood!cell! transfusion!had!associated!longer! days! of! invasive! ventilation,! increased! mortality,! and! increased! rate! of! nosocomial!infections!(34).!4.3!TRANSFUSION!PRACTICES!IN!PEDIATRIC!CRITICAL!CARE!!! In!pediatric!critical!care,!Bateman!et!al.!prospectively!evaluated!anemia!and!transfusion!practices!and!found!that!33%!of!children!who!stay!at! least!two!days!in!the!PICU!are!anemic!on!admission! to! the! PICU,! and! 41%! develop! anemia! over! the! course! of! their! stay,!mostly! due! to!frequent!blood!draws!which!average!5ml/day!(34).!In!2007,!the!TRIPICU!study!was!published!by!Lacroix! et! al.! demonstrating! that! a! Hb! of! 7g/dL! was! nonSinferior! to! 9.5! g/dL! in! critically! ill!
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children! that! were! stable! (38).! The! publication! changed! pediatric! transfusion! practice,! and!transfusion! thresholds! decreased! thereafter! (39).! Currently,! guidelines! support! the!recommendation! that! transfusion! should! be! considered! for! patients!with!Hb! between!5! and! 7!g/dL,!while!most!stable!PICU!patients!with!Hb!>7!g/dL!do!not!require!a!blood!transfusion!(6).!4.4!TRANSFUSION!IN!TRAUMA!PATIENTS!!! Hemorrhage! is!one!of! the! leading!causes!of! immediate!death! in! the!trauma!patient,!and!the! rapid! recognition,! and! control,! of! bleeding! is! crucial! to! the!management! of! these! patients.!!Current! guidelines! by! the!American! College! of! Surgeons,! recommend! rapid! consideration! of! O!negative! (OS)! blood! transfusion! in! the! unstable! trauma! patient! after! initial! fluid! bolus! (3).!Children,!as!opposed!to!adults,!have!a!tremendous!capacity!to!maintain!blood!pressure!by!raising!their! systemic! vascular! resistance,! and! therefore! the! recognition! of! critical! hypovolemia! and!shock!may! be!more! difficult.! Adult! studies! have! demonstrated! that! trauma! patients! receiving!blood!transfusions!have!worse!outcomes!(40,!41).!Restrictive!transfusion!strategies!have!never!been! applied! to! trauma! patients! as! they! are! often! considered! unstable!when! needing! a! blood!transfusion,! and! because! clear! determinants! of! blood! transfusions! in! trauma! have! never! been!described.!4.5!OBJECTIVE!AND!HYPOTHESIS!! The! objective! of! the! study! was! to! describe! the! red! blood! cell! transfusion! practices! in!pediatric! trauma! patients! admitted! to! the! critical! care! department.! Our! hypothesis! was! that!trauma! patients! are! transfused! at! a! higher! hemoglobin! level,! compared! to! other! patients!admitted!to!the!PICU.!Furthermore,!it!was!expected!that!the!study!would!provide!a!background!for! future!studies!and!assess!the! feasibility!of!applying!a!restrictive!transfusion!strategy! in!this!population.!
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CHAPTER!5.!METHODS!5.1!COHORT!STUDIES!! Despite!the!fact!that!randomized!controlled!trials!are!the!gold!standard!for!testing!certain!hypotheses! in! medical! research! and! to! study! the! efficacy! of! therapeutic! and! preventative!measures,! they! are! impractical! for! a! number! of! other! research! questions.!When! assessing! the!development! of! a! disease!or! exposure,! cohort! studies! are!better! suited! for! the! comparisons!of!exposed! and! unexposed! individuals.! One! cannot,! for! example,! be! randomized! to! anemia! or! to!trauma.!!
A! cohort! study! involves! following! a! group! of! subjects! though! time,! to! assess! the!appearance! of! risk! factors! or! risk!markers! and! the! development! of! certain! outcomes,! given! a!specific!exposure.!Analyses!are!then!undertaken!to!assess!if!the!exposure!–the!risk!factor!or!the!risk!marker,!is!associated!with!the!outcome!by!comparing!exposed!and!unSexposed!patients!(42).!For!example,!in!a!cohort!of!PICU!patients!the!patients!are!all!at!risk!of!anemia!(which!can!be!an!exposure)!and!subsequent!transfusion!(outcome).!Furthermore,!the!transfusion!can!be!assessed!as! an!exposure,! followed!by! the!development!of! a! complication! (outcome).!The! features!of! the!cohort! studies! allow! one! to! make! a! temporal! association! between! exposure! and! outcome,!although!causality!may!be!impossible!to!establish.!!




5.2.1!OBJECTIVE!OF!THE!STUDY!! The! objective! of! the! Bateman! study! was! to! evaluate! the! epidemiology! of! anemia! and!blood!transfusions!in!critically!ill!children!in!North!American,!as!well!as!determine!the!causes!of!ongoing!blood!loss!in!the!PICU.!!
5.2.2!STUDY!DESIGN!! A!large!international!multicenter!observational!study!was!undertaken!in!30!PICUs!across!North!American!that!were!members!of!the!Pediatric!Acute!Lung!Injury!and!Sepsis!Investigators!(PALISI)! network! in! 2004S2005.! The! study! design!was! a! prospective! cohort! of! all! consecutive!patients!admitted!to!the!PICU!for!over!48!hours,!in!order!to!describe!the!development!of!anemia!and!the!transfusion!practices!amongst!them.!There!was!no!specific!intervention!given!the!study!design,! and!participation!did!not! require! any! change! in! routine!medical! practice.!A!predefined!sample!size!of!1000!patients!was!targeted!for!inclusion,!after!which!point!enrolment!ended.!!
5.2.3!STUDY!POPULATION!! All! consecutive! children! admitted! to! the! PICU,! below! 18! years! of! age!were! eligible! for!enrolment!once!admitted!for!over!48!hours.!Patients!were!included!if!they!had!been!admitted!to!the! PICU! over! 48! hours! and! had! no! exclusions.! Exclusions! from! the! study! were! premature!neonates,! previous! participation! in! the! study,! family! history! of! refusing! blood! transfusion,!pregnancy,! involvement! in!other!transfusion!related!studies,! impending!brain!death!and!recent!admission!(within!7!days)!to!the!PICU!for!more!than!72!hours.!!
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5.2.4!DATA!COLLECTION!! All! information! after! the! first! 48! hours! was! prospectively! collected! whereas! the!information!on!the!first!48!hours!of!admission!(day!1!and!day!2)!was!collected!retrospectively.!Demographic!data,! admission!diagnosis,! comorbidities,! and! severity! scores! (PRISM! III,!PELOD)!were!recorded!on!admission!(see!Appendix!3!for!specifications).!All!laboratory!values!pertaining!to! transfusion! (hemoglobin,!hematocrit)!were! included.! Information!on!number!and!volume!of!blood!draws!were!included!daily.!All!complications!and!changes!in!patient!status!were!recorded!daily! including! mechanical! ventilation,! inotropic! support,! specific! technologies! (ECMO,! renal!replacement!therapy)!and!surgery.!For!every!transfusion!given,!preStransfusion!hemoglobin!and!physician! reasons! for! transfusion!were! recorded,! along!with! volume,! storage! time! and! type! of!transfusion.!!5.3!METHODOLOGY!FOR!SUBGROUP!ANALYSIS!! Subgroup! analysis! involves! evaluating! a! smaller! group! of! individuals! from! the! original!cohort!study!and!comparing! them!to! the!group!based!on!exposure!status! (42).! In! the!Bateman!study,!a!subgroup!of!99!trauma!patients!was!included!in!the!cohort,!as!defined!by!their!diagnosis!on!admission.!The!trauma!subgroup!was!then!compared!to!the!rest!of!the!PICU!cohort.!Because!the! subgroup! analysis!was! not! considered!a)priori,! trauma!mechanism,! location! of! injury,! and!solid! organ! damage! were! not! ! recorded! in! the! original! study,! and! this! information! was! not!available.!!
5.3.1!PATIENT!POPULATION!! The!subset!of!patients!included!in!the!original!Bateman!study!with!diagnosis!of!trauma!on!admission!constituted!the!trauma!group!in!our!analysis.!The!trauma!subgroup!was!compared!to!the! rest! of! the! original! cohort! of! PICU! admissions.! Transfusion! thresholds! for! cardiac! surgery!
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patients!(43)!and!patients!with!cyanotic!heart!disease!are!known!to!be!high!(44).!In!order!not!to!bias!the!comparison!group!toward!a!higher!transfusion!threshold,!these!patients!were!excluded.!Therefore,! all! patients! admitted! with! elective! cardiac! surgery,! and! all! patients! with! known!cyanotic!heart!disease!were!excluded!in!our!analysis.!!
5.3.2.!OUTCOMES!!! The!main!outcome!variables!assessed!were!transfusion!variables,!in!order!to!evaluate!the!determinants!of!receiving!a!red!blood!cell!transfusion!in!the!PICU.!We!assessed!preStransfusion!hemoglobin!levels,!number!of!transfusions,!dates!of!transfusion!in!both!trauma!and!nonStrauma!patients,!along!with!demographics!for!trauma!patients!and!factors!that!may!be!associated!with!a!blood! transfusion.! Complications! were! recorded! along! with! the! time! relevant! to! receiving! a!transfusion.!
5.3.3!DATA!COLLECTION!! Dr.!Lacroix,!as!a!coSauthor!of!the!original!Bateman!study,!provided!access!to!the!original!database.! Statistician! T.! Ducruet! extracted! desired! data! from! the! database,! and! oversaw! the!statistical!analyses.!No!additional!data!was!required!or!requested.!!
5.3.4!STATISTICAL!ANALYSIS!!! The!study! is!a!prospective!cohort!and! is!descriptive! in!nature.!Results!are!expressed! in!descriptive! terms;! mean! (SD),! median! (IQR),! number! of! patients! (%)! where! appropriate.!Comparison!of!means!was!performed!with!chiSsquared!test!for!outcomes!with!categorical!values,!and!Student!t!test!was!used!for!continuous!predictors.!The!proportion!of!transfused!patients!was!plotted!against!preStransfusion!hemoglobin!level!to!compare!preStransfusion!thresholds!between!trauma! and! nonStrauma! patients.! Multivariate! logistic! regression! was! used! to! predict!
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ABSTRACT%
Objective :! Describe! red! blood! cell! (RBC)! transfusion! practices! in! pediatric! trauma! patients!admitted!to!a!pediatric!intensive!care!unit!(PICU).!!
Design:%PostShoc!analysis!of!a!prospective,!6Smonth!observational!study!in!30!PICUs.!
Population:!Patients!<18!years!of!age!admitted!to!the!PICU!>!48!h!were!included.!Cardiac!surgery!and!cyanotic!heart!disease!were!excluded.!
Results :! Five! hundred! and! eighty! patients!were! enrolled! in! the! study,! of!which! 95!were! trauma!patients.! Trauma! patients! were! more! frequently! transfused! prior! to! PICU! admission! (p<0.001),!were!older!(p<0.0001)!and!more!frequently!mechanically!ventilated!(p=0.05).! In!the!PICU,!trauma!patients!were!also!more! likely!to!receive!a!transfusion!(55%!vs.!37%,!p<0.001)!despite!admission!hemoglobin! being! similar! in! both! groups! (p=0.86).! The!mean! preStransfusion! hemoglobin! in! the!PICU! was! 9.0!g/L! (SD! 2.4)! for! trauma! patients! compared! with! 8.3! g/L! (SD! 2.4)! for! nonStrauma!patients! (p=0.09).!Amongst! trauma!patients,! transfusion!was! associated!with! younger! age,! higher!PELOD,! mechanical! ventilation,! bleeding! and! transfusion! prior! to! PICU.! Multivariate! regression!analysis!demonstrated!that!receiving!an!RBC!transfusion!prior!to!admission!was!strongly!associated!with!receiving!a!blood!transfusion!in!the!PICU!(p=0.008).!
Conclusion :!Trauma!patients!are!at!high!risk!for!receiving!a!RBC!transfusion!both!prior!and!during!their! PICU! stay,! despite! a! similar! transfusion! threshold! compared! to! nonStrauma! patients.!Transfusion!prior!to!PICU!admission!is!a!strong!determinant,!suggesting!ongoing!bleeding!requiring!reStransfusion.! Further! studies! designed! for! trauma! patients! are! needed! to! evaluate! the! specific!determinants! of! transfusion,! in! order! to! safely! consider! restrictive! transfusion! strategies! in! this!group.!!
Keywords:!Trauma,!Pediatrics,!Transfusion,!Erythrocyte,!Red!blood!cell,!Critical!care,!Risk!factor% !
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INTRODUCTION!! Injury! is! the! leading! cause! of! mortality! in! children! over! 1! year! of! age,! with! traumatic!brain!injury!and!hemorrhagic!shock!being!the!primary!causes!of!death!amongst!them!(1S3).!Red!blood!cell!(RBC)!transfusion!is!an!important!component!in!the!acute!management!of!the!unstable!or!bleeding!trauma!patient.!Furthermore,!anemia!is!very!common!in!pediatric!intensive!care!unit!(PICU)!patients!(4).!Despite!the!risks!associated!with!severe!anemia,!increasing!data!suggest!that!significant! risks! are! associated! with! transfusion! (5,! 6).! Both! adult! and! pediatric! critical! care!practices!have!shifted!to!restrictive!transfusion!strategies!given!the!potential!adverse!outcomes!associated!with!transfusions!(5,!6).!!!Transfusion! guidelines! for! adult! trauma! cases! recommend! RBC! transfusion! for!hemorrhagic! shock,! or! hemodynamic! instability! with! acute! hemorrhage,! otherwise! suggest!transfusion!for!Hb!<7!g/dL!in!resuscitated!trauma!cases!(7).!Given!the!risks!associated!with!onSgoing! hemorrhage,! trauma! patients! may! not! be! subject! to! a! restrictive! transfusion! strategy.!!Adult!literature!has!shown!that!blood!transfusion!in!trauma!patients!is!common!(10S23%),!and!an! independent!predictor!of!mortality!and!prolonged!ICU! length!of!stay!(8,!9).!A!survey!on!the!stated! clinical! practice! and! determinants! of! RBC! transfusions! amongst! pediatric! critical! care!practitioners! revealed! that! high! PRISM! score,! active! bleeding! and! surgery,! were! statistically!significant! predictors! of! receiving! a! blood! transfusion! while! in! PICU! (10),! and! a! more! recent!survey!reported!mean!(SD)!transfusion!threshold!hemoglobin!of!8.1!±!1.2!g/dL!for!trauma!cases!(11).! Literature! however,! on! the! observed! transfusion! practice! in! severe! pediatric! trauma! is!lacking.!!The!objective!of!the!current!study!is!to!describe!the!RBC!transfusion!practices!in!pediatric!trauma!patients!admitted!to!the!PICU,!and!to!characterize!the!determinants!of!RBC!transfusion!in!this!population.!We!hypothesize!that!trauma!patients!are!transfused!at!a!higher!hemoglobin!than!nonStrauma!patients.!
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!
METHODS%This! study! is! a! postShoc! analysis! from! the! dataset! of! a! previous! large! multicenter!prospective!cohort!(4).!!
Study%population%and%Sites%The! original! cohort! study! was! prospectively! conducted! in! 30! American! and! Canadian!PICUs! that! are!members! of! the! Pediatric! Acute! Lung! Injury! and! Sepsis! Investigators! (PALISI)!Network,! for!6!months! from!September!2004! to!March!2005.!All! consecutive!patients!younger!than!18!years!of!age,!admitted!to!the!PICU!for!over!48!hours,!were!eligible.!Exclusions!from!the!original! study! included! premature! neonates,! prior! involvement! in! the! study,! family! history! of!refusing! blood! transfusions,! involvement! in! another! transfusion! study,! pregnancy,! impending!brain! death,! and! admission! to! the! PICU! for! more! than! 72!hours! in! the! last! 7! days.! Further!exclusions! for! the! purpose! of! the! present! study! included! all! patients! admitted! for! cardiac!surgery,! and! patients!with! cyanotic! heart! disease,! as! both! groups! of! patients! are! known! to! be!associated! with! higher! transfusions! thresholds! (12,! 13).! The! institutional! ethics! committee!approved! the! current! study! (#3997)! with! a! waiver! of! consent! as! no! new! information! was!collected!from!patients.!!
Data%collection%and%management%!Given!that!patient!inclusion!occurred!48!hours!after!PICU!admission,!all!data!in!the!first!48!hours!of!admission!were!collected!retrospectively!(except!blood!loss!data!which!was!captured!prospectively! from! admission! in! all! patients).! Trauma! patients! were! identified! from! database!based!on! the! reason! for!PICU! admission.!Data! collected!on! admission! included:! demographics,!severity!of!illness!as!estimated!by!Pediatric!Risk!of!Mortality!(PRISM)!III!score,!severity!of!organ!dysfunction! as! estimated! by! Pediatric! Logistic! Organ! Dysfunction! (PELOD)! score,! transfusions!prior!to!admission!and!baseline!hemoglobin!(Hb).!All!data!after!the!first!48!hours!of!admission,!
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including!blood!loss!information,!blood!transfusion!information,!clinical!parameters,!reasons!for!transfusion,! laboratory! values! (hemoglobin)! and! complications! were! collected! prospectively.!Only!events! that!happened!after! the! first!RBC! transfusion! in!PICU!were!considered!as!possible!transfusionSrelated!complications!in!order!to!prevent!any!protopathic!bias.!
Statistical%Analysis%Results!of!descriptive!statistics!were!expressed!as!a!fraction!of!the!total!population,!mean!±! standard! deviation! (SD),! or! median! with! interquartile! range! (IQR)! where! appropriate.!Categorical! variables! were! analyzed! using! ChiSsquare! statistics.! ! Continuous! variables! were!compared! using! analysis! of! variance! (ANOVA)! test! for! normally! distributed! variables,! and!Wilcoxon! test! for! discrete! variables! not! normally! distributed.! PSvalue! of! 0.05! was! chosen! as!statistically! significant.!Multivariate! analysis!was! performed! on! factors! found! to! be! significant!(p<0.05)! in! univariate! analysis,! with! no! interaction! and! that! were! not! redundant,! up! to! a!maximum!of!5!variables.!Results!are!reported!as!odds!ratio!(OR)!and!confidence! intervals!(CI).!All!statistical!analyses!were!done!by!a!biostatistician!(TD),!using!SAS!statistical!software.)
%
RESULTS%Of!the!977!patients!included!in!the!original!study,!580!patients!had!no!exclusion!criteria!and!were!included!in!the!analysis,!of!which!95!were!trauma!patients!and!485!were!nonStrauma!patients!(Figure!1A).!!
Trauma%vs.%nonZtrauma%patients%Demographics!for!trauma!and!nonStrauma!patients!are!described!in!Table!1A.!Compared!with!nonStrauma!patients,! trauma!patients!were! statistically!more! likely! to!be!older! (p<0.001)!and!mechanically! ventilated! (p=0.05).! Baseline! PELOD! and! PRISM! scores!were! similar! in! both!groups,!as!well!as!need!for!inotropic!support.)Trauma!patients!were!more!likely!than!nonStrauma!patients!to!have!hemorrhagic!shock!(p<0.001),!and!they!received!more!blood!transfusions!prior!
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to! PICU! admission! (57%! trauma! group! vs.! 38%! nonStrauma! group,! p<0.0001).! In! addition,!trauma! patients!were!more! likely! to! receive! a! transfusion! during! PICU! course! (55%! vs.! 38%,!p=0.002),!despite!similar!baseline!admission!hemoglobin!levels!in!each!group!(11.3!g/dL!vs.!11.1!g/dL,!p=0.86)!(Table!1).!Mean!preStransfusion!hemoglobin!in!the!PICU!was!9.0!g/L!(±2.4)!in!the!trauma! group! and! 8.3!g/L! (±! 2.4)! in! the! nonStrauma! group! (p=! 0.09),! with! a! proportionally!similar!distribution!of!preStransfusion!hemoglobin!(Figure!2A).!
Transfusion%practices%in%trauma%cases%Amongst!the!95!trauma!cases,!transfused!patients!were!more!likely!to!be!young!(p=0.02),!with!higher!PELOD! score! (p=0.03),!mechanically! ventilated! (p=0.04),! and!have! active!bleeding!(p=0.053)!on!admission!(Table!2).!Transfused!patients!were!also!more!likely!to!have!received!a!transfusion! prior! to! admission! to! PICU! (p<0.0001).! In! the! PICU,! mean! preStransfusion!hemoglobin! was! 9.0! g/L! (SD! 2.4)! in! the! transfused! trauma! group,! as! compared! to! nadir!hemoglobin! of! 9.8! g/L! (SD! 2.2)! in! the! nonStransfused! trauma! patients! (p=0.053)! (Table! 2A).!!There!were!8!cases!of!shock,!7!of!which!were!hemorrhagic,!and!all!were!transfused.!Head!injury!was! not! associated!with! receiving! a! blood! transfusion! in! trauma!patients.!Multivariate! logistic!regression!analysis!revealed!that!being!transfused!prior!to!PICU!was!strongly!associated!with!an!increased! likelihood! for! receiving! a! transfusion! in! the! PICU! (odds! ratio:! 17.7;! CI! 2.1! to! 147.4,!p=0.008)!(Table!3A).!The!majority!of! transfused!trauma!patients!(n=30,!58%)!received!their! first! transfusion!in! the! first!24!hours! after!PICU!admission! (Table!4A).!The!median!number!of!units! transfused!was! 1,! but! 8! patients! (15%)! required! more! than! 5! RBC! transfusions.! The! incidence! rate! of!transfusion!events!was!1.5!per!trauma!case.)Median!length!of!storage!of!transfused!RBCs!was!14!days!(IQR!9S21).!Stated!reasons! for! transfusion!are!presented! in!Table!5A.!The!primary!reason!for! transfusion! in! trauma! patients! was! low! hemoglobin! (44%),! emergency! surgery! (9%)! and!acute!blood!loss!(6%).!In!nonStrauma!patients,!the!primary!reason!for!transfusion!was!also!low!
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hemoglobin! (39%),! followed! by! a! large! variety! of! other! reasons,! including! extracorporeal!membrane!oxygenation!(ECMO)!and!aiming!to!increase!oxygen!delivery.!!
Outcomes%and%Complications%Table!6A!reports!adverse!events!observed!during!the!entire!PICU!stay!in!transfused!and!nonStransfused! trauma! patients.! PSvalues! are! not! presented! as! values! are! descriptive,! and! the!two! groups! are! poorly! comparable.! There! were! no! deaths! amongst! all! 95! trauma! patients!included!in!the!study.!!
%
DISCUSSION% %
In our study, trauma patients were more likely to be older and mechanically ventilated 
compared to non-trauma patients, but with similar severity scores and inotropic support. 
Furthermore, trauma patients admitted to the PICU had a higher likelihood of receiving a RBC 
transfusion prior to PICU admission, despite similar baseline hemoglobin levels compared to 
non-trauma patients. Following PICU admission, trauma PICU patients are more likely than 
non-trauma patients to receive a blood transfusion (55% vs 37% respectively, p<0.001) even 
though their hemoglobin level was similar at PICU entry (p=0.86) and pre-transfusion in PICU 
(p=0.09). Amongst trauma patients, transfusion was associated with younger age, higher 
PELOD, mechanical ventilation, active bleeding and transfusion prior to PICU. These findings 
suggest that trauma patients may already be subject to a restrictive transfusion strategy, or more 
likely that they bleed rapidly, requiring subsequent transfusion prior to and on arrival to PICU. 
Amongst pediatric trauma patients admitted to the PICU, the likelihood of RBC 
transfusion increases as the severity of injury increases (12, 14), with the incidence rate of 
transfusion in pediatric trauma patients ranging from 5% to 30% (15-17). We observed an 
incidence rate of 54.7%. This higher incidence of transfusion may be due to data collected prior 
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to the TRIPICU study of restrictive transfusion practices in critically ill children (6), or overall 
sicker patients given inclusion only of patients admitted > 48h in PICU.  
Predictors of transfusions in adult trauma patients include low hematocrit, indices of 
shock (lactate and base deficit), low Glasgow Coma Score, and penetrating trauma (9, 18, 19). 
A retrospective study in all pediatric trauma patients by Allen et al. reported that hematocrit, 
glascow coma score (GCS), base deficit and Injury Severity Score (ISS) were associated with 
receiving a blood transfusion, with hematocrit remaining an independent predictor on 
multivariate analysis (16). Our predictors of RBC transfusion, in severe trauma patients 
admitted to the PICU, include young age, severity of illness measured by PELOD score, and 
transfusion prior to admission, with the latter being strongly associated in multivariate analysis. 
This suggests that in severe trauma patients, transfusion before likely means transfusion after 
PICU admission. Bleeding therefore, whether visible or occult, must be suspected and managed 
rapidly as suggested by Advanced Trauma Life Support management (20).  
Despite the above predictors, both the surgical and resuscitative management of trauma 
patients is moving toward more conservative management, with increasing evidence for harmful 
effects of interventions in trauma. In terms of surgical care, current standard of care in stable 
patients with solid organ injury is non-operative management, a practice initiated by the 
pediatric population (21-25). A randomized controlled trial evaluating liberal vs. restrictive fluid 
strategies in trauma suggested that initial liberal fluid management might be harmful (26). The 
harmful effects of blood transfusion have also been established in adult trauma patients (8, 27, 
28), and more recently in pediatrics (17). Hasan et al. previously reported an increased risk of 
adverse events, including mechanical ventilation and mortality, in pediatric trauma patients 
having received a blood transfusion (17). Nosanov et al. demonstrated that in a group of 
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massively transfused pediatric trauma patients, mortality was related to neurologic injury and 
coagulopathy (15). Multiple adult studies have also suggested harmful effects of transfusion in 
traumatic brain injury (TBI) patients, despite the evidence suggesting that anemia is detrimental 
in TBI (29,30). It is unclear however, that transfusion practices have changed significantly in 
pediatrics, in trauma and in the intensive care unit. A recent study by Klaus et al. concluded that 
pediatric transfusion triggers remain above 7 g/dL, and vary widely (> 2.5 g/dL) within and 
between pediatric subspecialties (31). No literature currently exists specifically for transfusion 
in trauma patients, let alone changes in transfusion practice.  This study should therefore serve 
as a baseline for transfusion practice in pediatric trauma.  
In terms of adverse events, we described that re-intubation, fluid overload, cardiac 
dysfunction and non-hemolytic fever, are relatively frequent after patients received blood 
transfusions in the PICU. Despite wide distribution, length of stay was longer in transfused 
group. These results must be interpreted with caution because our sample size is small, and 
unadjusted for severity of illness in transfused patients. Noteworthy, we were able to 
discriminate the adverse events that occurred after transfusion from those already present prior 
to the transfusion to avoid protopathic bias, or lagging, which is rarely taken into account in 
similar observational studies. It is impossible to conclude however, with a prospective study 
design, whether the adverse outcome was associated with the exposure or the patients’ baseline 
characteristics. In any case, a randomized trial of different transfusion strategies in trauma cases 
would be necessary to conclude on the adverse events associated with RBC transfusion in this 
group.  
A limitation of the current study is the lack of information with respect to mechanism of 
injury, type of trauma (blunt or penetrating), bleeding sites, organ involvement and types of 
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emergency surgery required. Pelvic fractures, penetrating injury, open long bone fractures, 
splenic lacerations and scalp lacerations can lead to massive blood loss. These factors may also 
be independent determinants of receiving a transfusion in the PICU as supportive non-operative 
care, including blood transfusion, is the standard of practice for hepatic, splenic and renal injury 
in hemodynamically stable children (23-25). Indeed, conservative management has been 
suggested to reduce blood utilization in this population (32), but before restrictive transfusion 
strategies are implemented, prospective studies in trauma patients detailing types of injury and 
ongoing hemodynamic stability are needed.  
In addition, the data used for the study dates back to 2005, and may not reflect current 
transfusion practices as it predates the publication of the TRIPICU study, which supports 
restrictive transfusion strategies in critically ill children (6). As stated above, it is unclear 
whether transfusion practices have changed significantly in the last few years. Surgical and 
acute care pediatric subspecialties (orthopedics, general surgery, general pediatrics, PICU) 
continue to transfusion at a higher Hb trigger than recommended by a restrictive strategy (31), 
and this study allows us to establish a baseline transfusion trigger and determinants in severe 
pediatric trauma.  
Another possible limitation is the study only included patients admitted to the PICU for 
over 48h, which represents about 20% of the PICU population. Therefore, there may be a 
selection bias for more severe and unstable trauma patients. Small sample size prohibited 
calculation of interaction in multiple regression analysis. 
In summary, our study is an important step in the understanding of transfusion practices 
in pediatric trauma patients. As we move toward a culture of harm reduction in transfusion 
practice through restrictive transfusion protocols, it remains important to ensure that certain 
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groups, such as trauma patients, are not at increased risk. Trauma patients admitted to the PICU 
are at high risk for receiving a RBC transfusion both prior and during their PICU stay. The risks 
associated with RBC transfusion must be balanced with the risk of hemorrhagic shock and 
anemia in trauma. A reliable knowledge of RBC transfusion practices in pediatric trauma cases 
is critical in the preparation of future interventional trials, as transfusion thresholds in this group 
have not been established, and increasing literature indicates harmful outcomes related to RBC 
transfusions. Randomized controlled trials are required to determine what would be the optimal 
RBC transfusion practice in severe pediatric trauma. 
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Figure%1A.%Flowchart%of%Patients%included%in%study%a. Includes!patients!admitted!to!critical!care!unit!for!elective!or!emergency!cardiac!surgery!not!related!to!trauma!!b. Includes!!all!patients!with!cyanotic!heart!disease!not!admitted!for!cardiac!surgery!(*!1!patient!labeled!at!admission!for!Trauma,!+!Emergency!Cardiac!Surgery!+!Cyanosis!was!excluded)!! !
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Characteristics%of%Patients%Transfused% N=52!Transfused!cases,!n!(%!of!all!trauma!patients)! 52!(54)!Incidence!rate!of!transfusion!(transfusion!events/1case!trauma)! 1.5!Volume!of!Blood!during!first!PICU!transfusion!(ml/kg),!median!(IQR)a! 10!(5S15)!Time!from!entry!to!first!transfusion!(days),!n(%)! !!!!!!!!!!Day!1!! 30!(58)!!!!!!!!!!Day!2!!!!!!!!!!! 8!(15)!!!!!!!!!!Day!3!!!!!!!!!!! 6!(11)!!!!!!!!!!Day!4!!!!!!!!!!! 4!(8)!!!!!!!!!After!Day!5!!!!!!!!!!! 4!(8)!Number!of!patients!who!received!1!transfusion!in!PICU! 21!(40)!Number!of!patients!who!received!2!transfusions!in!PICU! 13!(25)!Number!of!patients!who!received!3!transfusions!in!PICU! 1!(2)!Number!of!patients!who!received!4!transfusions!in!PICU! 9!(17)!Number!of!patients!who!received!>5!transfusions!in!PICU! 8!(15)!
















% Prior!to!1st!Transfusion! Post!1st!Transfusiona! !Entire!PICU!stay!Complications,!n!(%)! ! ! !Respiratory!dysfunction!! 6!(11)! !9(16)! 6!(14)!Reintubation! 2!(4)! 7!(13)! 3!(7)!Fluid!overload!(CVP!>8mmHg)! 8!(15)! 8!(15)! 3!(7)!Cardiovascular!dysfunction! 5!(10)! 8!(15)! 2!(5)!Systemic!inflammatory!response! 10!(19)! 13!(25)! 7!(16)!Hematologic!dysfunction! 0!(0)! 3!(6)! 1!(2)!Acute!nonShemolytic!fever! 11!(21)! 13!(25)! 7!(16)!Nosocomial!infectionb! 14!(27)! 5!(10)! 13!(30)!Neurologic!dysfunction! 9!(17)! 11!(21)! 5!(12)!Length!of!stay!in!days,!mean!(SD)! 10.8!(7.2)! 5.1!(3.8)!Mortality,!n!(%)! 0!(0)! 0!(0)!!a!Occurring!during!or!within!first!48h!after!transfusion!in!transfused!patients!b!Includes!Catheter!related!infection,!Nosocomial!pneumonia,!sinusitis!and!UTI,!as!well!as!“other”!nosocomial!infection.!
% !
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CHAPTER!7.!DISCUSSION!7.1!DISCUSSION!AND!CHALLENGES!ENCOUNTERED!IN!OSMOTHERAPY!STUDY!!! The! paucity! of! literature! for! osmolar! agents! in! pediatric! TBI! created! a! good! starting!ground! from! which! this! study! arose.! In! order! to! establish! the! practices! in! our! center,! and!practices! in! TBI,! this! retrospective! study! was! undertaken.! Understanding! the! clinical! issues!surrounding!the!administration!of!hyperosmolar!agents!was!crucial!to!prepare!for!future!studies,!and!attempting!to!quantify!their!effect!on!ICP!has!rarely!been!evaluated!in!pediatrics.!We!sought!to!describe!practice,!reasons!for!the!choice!of!osmolar!agent,!and!mostly!to!evaluate!the!effect!of!both!mannitol!and!hypertonic!3%!saline!on!ICP.!
7.1.1!SAMPLE!SIZE!!! In! terms! of! practice! description,! the! study! confirmed! that! neuromonitoring! is! not!consistently!undertaken! in!pediatric! severe!TBI.!The!number!of!patients!meeting!eligibility! for!the! study! was! below! what! we! had! initially! predicted.! We! can! be! thankful! for! public! health!promotion! reducing! the!number!of!deaths!associated!with!motor!vehicle!accidents! in! children,!and! the! number! of! unrestrained! passengers;! however,! a! major! limitation! was! the! number! of!severe! TBI! patients! and! consequently! the! number! with! an! ICP! monitor.! Our! first! study! (not!discussed!above)!attempted!to!address!the!reasons!for!low!ICP!monitoring!rates!in!severe!TBI.!It!revealed! that! many! severe! TBI! patients! either! have! an! improving! GCS! score,! or! a! moribund!status,!both!of!which!can!preclude! ICP!monitoring!(18)!(see!Appendix!1).!Once!an! ICP!monitor!was!placed!in!the!persistently!comatose!child,!hyperosmolar!agents!were!then!often!given.!!
! The!lower!rate!of!ICP!monitoring!in!our!center!is!in!line!with!previous!literature!on!low!rates!of!ICP!monitoring!in!pediatrics!(15S17,!45),!with!the!neonatal!and!infant!group!being!less!
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frequently! neuromonitored.! This! highlights! that! our! practice! is! likely! similar! to! other! large!pediatric!centers,!supporting!its!external!validity.!
! Challenges! in! achieving! adequate! sample! size! may! then! affect! the! possibilities! of!statistical!analysis!that!one!can!conduct.!We!were!unable!to!compare!the!effect!on!ICP!of!boluses!of!mannitol! versus!3%!hypertonic! saline!between!each!other,! although! this!was!not! set! as! the!primary!outcome.!When!a!small!subset!of!patients!is!analyzed!over!multiple!years,!the!effect!of!changes! in! clinical! practice! and! choice! of! agents! may! confound! results.! Furthermore,! coSinterventions! affecting! ICP! have! more! important! statistical! weight! when! using! small! sample!sizes,!and!a!positive!effects!is!then!difficult!to!detect.!
7.1.2!STANDARDIZING!PRACTICE!! The! lack!of!a! standardized!protocol! for! sedation!and!escalation!of! therapy!was!another!barrier! that!will! need! to!be! addressed!prior! to! prospective! studies.! Sedation! regimens! (agents!and!doses)!varied!greatly! from!one!patient! to!another,!and!there!was!no!specific! threshold! ICP!for! administering! a! hyperosmolar! agent,! or! escalation! protocol! for! uncontrolled! ICP.! This!resulted! in! agents! being! given! systematically,! or! without! intracranial! hypertension! (ICP!<20mmHh).! Patients! therefore! were! difficultly! comparable! at! baseline.! There! was! possibly! a!decreased!effect!size!related!to!this!interSsubject!variability.!!
Mannitol!was!less!frequently!administered!than!hypertonic!saline,!making!the!group!size!quite! small.!The! lack!of!adequate!sample!size!made!comparison!of! the!2!groups! (mannitol!and!hypertonic! saline)! impossible,! and! the! mean! difference! between! groups! would! have! been!inaccurate.! Larger! group! size! and! more! frequent! data! points! post! bolus! would! increase! the!power!need!to!compare!the!2!agents.!We!did!not!identify!any!specific!factors!for!the!choice!of!one!agent!versus!the!other.!Low!admission!sodium!did!not!appear!to!dictate!choice!of!hyperosmolar!
! 65!
agent,!and!the!higher!rate!of!3%!hypertonic!saline!used!as!first!hyperosmolar!agent!may!reflect!level!II!guideline!recommendations!in!pediatrics,!although!this!cannot!be!validated.!
7.1.3!FREQUENCY!OF!COSINTERVENTIONS!! One!of!the!challenges!during!the!study!was!the!frequency!of!coSinterventions!to!decrease!ICP,!which!were!administered!post!bolus.!Intending!to!monitor!ICP!for!4h!post!bolus,!we!ran!into!frequent! coSinterventions! (repeated! hyperosmolar! agents,! propofol,! intermittent! sedation,!barbiturates).! The! period! following! administration! of! hyperosmolar! agents! was! therefore!frequently! contaminated!with! interventions! to! reduce! the! ICP,! and! future! studies!will! need! to!take! this! into! account.! ! The! possible! confounders! associated! with! these! coSinterventions! will!therefore! affect! the! internal! validity! of! the! study.! We! considered! censoring! all! data! points!occurring! after! a! coSintervention,! however! the! small! sample! size! did! not! permit! this! type! of!analysis! and! conclusions! would! have! been! invalid.! ! As! mentioned! previously,! a! standardized!protocol!for!escalation!of!sedation!and!management!of!high!ICP!will!also!address!this!challenge.!
7.1.4!FUTURE!DIRECTIONS!IN!PEDIATRIC!OSMOTHERAPY!! Regardless!of!an! increase! in!sample!size,! there!are! inherent!biases! to!retrospective!and!observational! studies! where! only! simple! associations! can! be! made.! Indeed,! in! order! to! truly!address!the!effect!of!both!mannitol!and!hypertonic!saline!on!a!reduction!of!intracranial!pressure,!and! the! superior! agent! amongst! the! two,! a! randomized! controlled! trial! is! necessary.! A! recent!study!by!Shein!et!al,!was!the!first!to!prospectively!report!pharmacotherapeutic!ICP!reduction!in!children! with! severe! TBI! (46).! After! coSvariate! adjustment,! they! found! that! hypertonic! saline!(3%)!and!phenobarbital!were!associated!with!ICP!reduction.!Given!the!small!number!of!eligible!patients! in! individual! centers,! a! multicenter,! perhaps! even! international,! trial! would! be!warranted.! A! minimum! of! about! 20! patients! per! group! (40! patients! in! total)! would! likely! be!
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necessary!to!detect!a!change! in! ICP!post!bolus.! !To!control! for!both!within!center!and!amongst!center!variation!in!practice!and!care,!a!standardized!protocol!for!the!management!of!severe!TBI!patients!would!be!necessary!including;!criteria!for!invasive!ICP!monitoring,!serial!data!collection,!invasive! arterial! monitoring,! temperature! and! position! control,! standardized! ventilation,!protocolized!sedation,!specific!criteria!for!administration!of!a!hyperosmolar!agent!and!scheduled!blood! sampling.! A! standardized!management! protocol! based! on! guidelines!would! support! the!external!validity!of!such!a!trial.!!




7.2!DISCUSSION!AND!CHALLENGES!IN!TRANSFUSION!IN!TRAUMA!STUDY!7.2.1!DATA!SUBSET:!STRENGTHS!&!LIMITATIONS!!! The! data! used! for! this! study! on!RBC! transfusion! practices! in! pediatric! trauma!patients!admitted!to!the!PICU!was!very!high!quality,!prospectively!collected!and!included!a!large!sample!size!of!patients!from!many!institutions.!Blood!loss,!blood!draws,! interventions!and!transfusions!were!all!very!well!documented,!along!with!all!serial!laboratory!values!related!to!transfusion.!The!data!subset!however,!is!now!10!years!old.!
! We!demonstrated!that!transfusion!in!trauma!patients!was!related!to!younger!age,!higher!PELOD! score,! mechanical! ventilation,! and! mostly! to! receiving! a! blood! transfusion! prior! to!admission! to! the!PICU.! Interestingly,! the!preStransfusion!hemoglobin! level! in! trauma! and!nonStrauma! patients! did! not! differ! significantly,! suggesting! the! adoption! of! an! already! restrictive!transfusion!strategy,!or!that!they!bleed!rapidly!requiring!transfusion.!
One! of! the!major! drawbacks! in! this! study!was! the! age! of! the! data! (2005).! It! is! unclear!whether! transfusion!practices! have! changed! over! the! last! decade,! but! certainly! the! findings! of!nonSinferiority! in! the! 2007! TRIPICU! study! had! a! major! impact! on! transfusion! thresholds! in!pediatrics!(38,!39).!The!awareness!of!the!harmful!effects!of!blood!transfusions!may!mean!that!we!are!more! frequently! applying! restrictive! transfusion! thresholds! to!patients.!A! recent! article! by!Klaus!et!al.!however,!demonstrates!that!clinical!practice!continues!to!transfuse!patients!above!a!restrictive!transfusion!strategy!in!pediatric!academic!centers!(47).!This!suggests!that!transfusion!practice!is!still!not!totally!restrictive.!
Another!potential!limiting!factor!was!that!the!study!was!not!designed!for!trauma!patients,!and!therefore!important!elements!about!initial!traumatic!lesions!are!not!included.!There!was!no!information! in! the! database! on!mechanism! of! injury,! organ! involvement,! blunt! or! penetrating!
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injury,!and!initial!resuscitation!to!further!classify!which!trauma!patients!may!be!at!increased!risk!of!hemorrhage!requiring!transfusion.!!
The!database! for! the!study!was!also!difficult! to!access! for!someone!who!quite! junior! in!statistics!and!programming,!but!easily!is!done!so!with!the!help!of!a!statistician.!Data!output!was!performed!by!statistician!T.!Ducruet.!Some!specific!data!were!not!obtained!(initial!lactate!levels,!rate! of! drop! of! hemoglobin,! lowest! blood! pressure! on! arrival…)! because! of! barriers! in! data!extraction,! or!difficult! coding.! Independent!variables! therefore!were!adjusted! to!obtain! related!information!in!order!to!draw!conclusions.!
7.2.2.!CATEGORIZING!RISK!BASED!ON!THE!INITIAL!STABILITY!!! Our! study! determined! that! trauma! patients! admitted! to! the! PICU! are! at! high! risk! for!receiving! a! blood! transfusion! and! to! be! transfused! early.! Furthermore,! transfusion! prior! to!arrival! to! the! PICU! is! an! independent! risk! factor! for! receiving! a! blood! transfusion! after! PICU!admission.! This! suggests,! that! those! patients! that! bleed,! bleed! substantially,! requiring! ongoing!transfusion!to!maintain!stability.!Interestingly!enough,!the!admission!hemoglobin!is!the!same!for!both!groups!(trauma!and!nonStrauma),!suggesting!that!there!is!necessarily!correction!of!the!low!hemoglobin! prior! to! admission,! despite! ongoing! bleeding.! Therefore,! it! must! be! possible! to!initially! identify! the! risk! factors! for! those!with!major!bleeding!and! instability! to!predict!which!patients! will! require! further! blood! products,! as! opposed! to! those! who! can! be! managed!conservatively.! A! retrospective! review! of! pediatric! trauma! patients! conducted! by! Allen! et! al.!found! that! hematocrit,! GCS,! base! deficit! and! increased! severity! score! were! associated! with!receiving! a! blood! transfusion! (48).! A! recent! retrospective! study! of! pediatric! trauma! patients!found!that!children!who!received!a!blood!transfusion!were!at!higher!risk!of!needing!mechanical!ventilation! and!mortality;! and! this! independent! of! severity! of! illness! (49).! Characterizing! this!
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risk,!and!the!severity!of!those!likely!to!require!a!transfusion,!will!be!the!next!step!in!establishing!the!feasibility!and!safety!of!restriction!transfusion!in!this!group.!! !7.2.3.!FUTURE!DIRECTIONS!IN!TRANSFUSION!IN!TRAUMA!!! To! further! understand! transfusion! practices! in! trauma,! a! prospective! multicenter!transfusion! trial! including! pediatric! trauma! patients! is! necessary.! With! a! study! specifically!designed!for!trauma!patients,!included!immediately!at!presentation!to!hospital,!one!will!be!able!to!characterize!the!clinical!features!and!laboratory!parameters!associated!with!transfusion.!This!type!of!study!is!of!course!difficult!to!perform,!as!consent!for!a!severe!trauma!patient!is!difficult!to!obtain!given!the!acuity!of!the!clinical!setting.!Nonetheless,!a!prospective!trial!in!trauma!patients!is!warranted! in!order! to! eventually! consider! the!necessity! for! a! randomized! trial! of! restrictive!transfusion!in!stable!trauma!patients.!
Furthermore,!therapies!attempting!to!control!bleeding!are!also!lacking!in!pediatrics,!but!would! likely! be! beneficial! in! the! trauma! patient.! Tranexamic! acid! has! been! shown! to! improve!mortality,! and! death! due! to! bleeding,! in! adult! trauma! patients! when! given! early! in! trauma!management! (CRASH!S2!Trial)! (50),!but! is!currently!not!used!as!standard!of!care! in!pediatrics.!Conducting!trials!of!tranexamic!acid!in!the!pediatric!trauma!patient!would!help!identify!whether!tranexamic!acid!could!be!beneficial!when!administered!in!this!population.!
!CHAPTER!8.!!LESSONS!LEARNED!DURING!MY!MSC!8.1!FEASIBILITY!! If!I!had!one!thing!to!tell!a!future!potential!MSc!candidate,!I!would!say:!“Think!small,!not!big”.!It!seems!somewhat!contradictory,!as!it!is!the!exact!opposite!message!I!tell!my!three!year!old!when! I! say;! “You! can! do! and! be! anything”.! It! is! in! fact! true! though! for! research,! and! the!
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completion!of!an!MSc.! I!have! learned!that!projects!must!be! feasible,!and! in!a! timely!manner,! in!order! to! produce! quality! results! and!maintain! the! desire! to! pursue! research.! One!must! learn!about!drafting!a!protocol,! ethics!approval,!data!collection,!analysis,! reSanalysis,! article!drafting,!and! literature! review! all! in! a! very! short! time.! If! data! collection! is! too! tedious,! or! statistical!analysis!to!impossible!for!a!junior,!then!one!can!get!rapidly!discouraged,!and!completion!may!be!quite! delayed.! I! was! lucky! enough! to! produce! three! articles! from! my! MSc! research! due! to!excellent! supervision,! an! existing! data! set! in! one! case,! statistical! aid! from! my! research!department,!and!a!tight!schedule!to!complete!given!tasks.!!8.2!DATA!COLLECTION!!! Once! must! have! gone! through! the! tedious! hours! of! data! collection! and! entry! to!comprehend! the! length,! the! coding! of! variables,! the! difficulty! in! deciphering! charts,! and! the!importance!of!knowing!what!nonSsuperfluous!information!to!gather.!Realizing!that! information!in!charts!may!be!incomplete!or!missing,!or!is!often!very!difficult!to!retrieve,!can!compromise!the!internal! validity! of! the! study.! Furthermore,! it! is! an! exercise! in! patience! that! researchers!must!endure!and!hope!to!pass!off!to!more!junior!collaborators!over!time.!!
! Furthermore,! the! importance! of! a! sound! research! question! with! specific! outcome!variables! is!crucial! in!the!creation!of!a!database,!so!as!not!to!return!into!charts! for!a!second!or!third!time!to!gather!additional!information!not!initially!considered.!In!addition,!not!having!direct!access!to!the!data,!and!data!collection!process,!may!prove!to!be!a!further!challenge.!!!! !8.3.!STATISTICAL!CHALLENGES!! !! One!should!know!how!to!perform!some!basic!statistics.! I! learned!this! too! late! I!believe,!and!needed!to!be!coached!in!the!end.!I!was!spoiled!with!the!extraordinary!help!of!a!statistician!on!my!project!on! transfusion,!and! this!did!not!properly!equip!me! initially.!Courses! in!statistics!
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and!hours!on!the!computer!with!data!cleaning!clarified!the!importance!of!this!skill!in!completing!my!projects.!
!8.4.!THE!IMPORTANCE!OF!SUPERVISION!! !! The! importance! of! adequate! supervision! during! research! training! cannot! be! stressed!enough.! As! a! resident/clinician! in! clinical! research,! time! is! often! divided! between! clinical!responsibilities,! call,! administrative! duties,! course!work! and,! if! one! has! time,! eventually! some!personal! life.! Access! to! timely! feedback! and! responses! to! research! questions! are! crucial! to! be!able!to!progress!within!research.! If!a!question! is! left!answered!about!methods,!data!extraction,!what!statistical!test!to!use,!the!entire!project!can!be!significantly!delayed.!One!needs!supervisor!availability!to!provide!structured!feedback,!support,!and!timely!responses!to!research!questions.!
8.5!DIRECTIONS!FOR!THE!FUTURE!! !! Both!my!clinical!work!and!research!projects!have! incited!me!to!pursue!research.! I!have!become! acutely! aware! of! the! lack! of! literature! and! evidence! for!much! of! the!medical! care!we!provide,!and!remain!interested!in!care!that!reduces!patient!morbidity.!In!fact,!I!have!developed!a!passion! the! maintenance! of! patient! safety! standards.! With! this! in! mind,! the! next! step! in! my!medical!and!research!endeavors!is!a!PhD!in!Clinical!Epidemiology!at!the!University!of!Toronto,!to!which!I!have!already!been!accepted!upon!completion!of!this!MSc.!My!future!projects!will!focus!on!the!epidemiology!and!the!harm!related!to!medication!errors!in!the!PICU.!I!do!intend!to!continue!working! on! improving! the! literature! and! the! care! for! trauma! patients;! both! in! future! TBI!protocols!for!pediatrics!and!transfusion!practices.!
!
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Abstract
Background Despite pediatric guidelines, variability exists in
the management of severe traumatic brain injury (TBI), as
somewhere between 7 and 60 % of children undergo intracra-
nial pressure (ICP) monitoring. Reasons for this low adher-
ence to TBI management guidelines remain unclear. The ob-
jective of this study was to evaluate the current practices at
CHU Sainte-Justine with regards to ICP monitoring in severe
TBI and explore the reasons why ICP monitoring is not
undertaken.
Methods A retrospective review was conducted of all patients
age 1 month to 18 years, with severe TBI (Glasgow Coma
Scale (GCS) ≤8) from 2007 to 2014. Presence of ICP moni-
toring, head imaging reports, and reasons for lack of monitor-
ing were recorded.
Results Sixty-four patients with severe TBI were admitted.
Twenty (31 %) patients had invasive ICP monitoring in the
first 6 h and 5 in the following 24 h. Improvement of the GCS
on arrival to tertiary care center (20 %, n=13) and moribund
status (20 %, n=13) were the two main reasons ICP monitor-
ing was not undertaken. Fourteen patients (21 %) with
reassuring cerebral tomography (Rotterdam scores 1–3) and
median GCS 7 (IQR 6–8) were initially followed with clinical
surveillance, five of which ended up with an ICP monitor
(>6 h).
Conclusion Our study confirms that many children with se-
vere TBI do not undergo ICP monitoring, mainly due to rapid
improvement or moribund status. A subgroup of patients, with
reassuring cerebral CT scan, was not monitored. Further re-
search is necessary to assess if imaging should be considered
in ICP indication, as in adult guidelines.
Keywords Traumatic brain injury . Pediatric . Intracranial
pressuremonitoring . Practice guidelines . Glasgow coma
score
Introduction
Trauma is one of the leading causes of death in children aged 1
to 18 years [1]. Ten percent of traumatic brain injury (TBI) is
considered severe [2], defined as an initial Glasgow Coma
Scale (GCS) ≤8, with high morbidity and mortality [3, 4].
Current adult and pediatric guidelines for the management of
severe TBI suggest that patients should undergo invasive in-
tracranial pressure (ICP) monitoring, despite a lack of grade 1
evidence [5, 6]. Literature, however, reports considerable var-
iability in the use of ICP monitoring in children, with partic-
ularly low rates in infants and toddlers [7, 8]. A large prospec-
tive UK database found that 59 % of children with severe TBI
underwent ICP monitoring [7], whereas queries of the United
States National Trauma Data Bank found rates of 8 % [9] and
27 % [10], respectively. These studies lack the details with
regards to why ICP monitoring is not undertaken. To date,
no studies have investigated the reasons for lack of ICP mon-
itoring in children.
The objective of this study was to evaluate our current
practices with regards to ICP monitoring and explore the rea-
sons for which monitoring was not undertaken.
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A retrospective chart review of all consecutive TBI patients
admitted to CHU Sainte-Justine between April 2007 and April
2014 was conducted. Patients between 1 month and 18 years
of age were included if their GCS after initial stabilization was
≤8. Sainte-Justine Hospital is a university-affiliated tertiary
care center in Montreal, Canada, and a reference center for
pediatric trauma. Patient demographics, mechanism of injury,
and clinical data were obtained from the chart. Placement of
ICP monitor in the first 6 h was considered in line with guide-
lines. Reasons for lack of ICP monitoring were obtained from
neurosurgical and intensive care charting. Final head CT re-
ports were reviewed retrospectively for Rotterdam scoring
[11]. Although conceived in adults, the score has recently
been used for mortality risk stratification in children [12].
Table 1 Baseline characteristics of patients
All patients, N=64 ICP monitor, N=25 No ICP monitor, N=39
Age (mean years±SDa) 8.3±5.6 9.7±5.2 7.3±5.8
Patients aged <2 years (no. (%)) 12 (19) 2 (8) 10 (26)
Male sex (no. (%)) 39 (61) 19 (76) 20 (51)
Mechanism of injury (no. (%))
Accident auto-pedestrian 9 (14) 3 (12) 7 (18)
Accident auto-bicycle 6 (9) 2 (8) 3 (8)
Accident auto-auto 20 (31) 7 (28) 13 (33)
Accident ATVb 2 (3) 1 (4) 1 (3)
Sports injury 2 (3) 1 (4) 1 (3)
Fall 5 (8) 2 (8) 3 (8)
Suspected abuse 9 (14) 2 (8) 7 (18)
Other 11 (17) 7 (28) 4 (10)
Initial GCS (median score (25th–75th percentile)) 6 (4–7) 6 (4–7) 6 (4–7)
Pediatric trauma scorec (median score (25th–75th percentile)) 5 (2–7) 5 (3–7) 4 (1–7.5)
Polytrauma (no. (%)) 27 (42) 11 (44) 16 (41)
External ventricular drain (no. (%)) 2 (3) 2 (8) 0 (0)
Death (no. (%)) 19 (30) 6 (24) 13 (33)
a Standard Deviation
bAll Terrain Vehicle
c Score range from −6 to +12 with lower score associated with increased mortality
Fig. 1 Flow chart of patients
included in study
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The study was approved by the research ethics board of our
institution (#3546) with a waiver of consent.
Results are expressed in proportions and mean or
median values, with respective standard deviations
(SDs) and interquartile range (25th–75th percentile)
when appropriate.
Results
Seventy-six patients with TBI were identified during the study
period, and 64 patients with severe TBI met inclusion. Patient
demographics are described in Table 1. A description of pa-
tient management is described in Fig. 1. Of the 64 patients, 20
(31 %) underwent immediate ICP monitor placement in the
first 6 h after arrival to the emergency department. Of the 44
patients (68 %) who did not undergo immediate ICP monitor-
ing, the primary causes were improving GCS on arrival (n=
13, 20 %) and moribund status (n=13, 20 %) as well as deci-
sion for clinical surveillance (N=14, 22 %). There were four
patients for whom it was unclear based on chart data why ICP
monitoring was not undertaken. In the patients managed with
clinical surveillance (N=14), five eventually underwent ICP
monitor placement in the first 24 h (range 7–21 h) and nine
clinically improved not requiring invasive monitoring. The
Rotterdam CT head scores of those managed with clinical
surveillance are presented in Table 2. All of the patients with-
out ICP monitor had a favorable clinical outcome, and one
death occurred in a patient with delayed ICP placement
(>6 h). A total of 25 patients (39 %) therefore underwent
ICP monitor placement of the 64 severe TBI patients.
Twenty-five percent of our patients were below 2 years of
age, and only 20% of those (2/10) underwent ICPmonitoring.
Discussion
Our study confirms that a minority of pediatric patients with
criteria for ICP monitoring actually undergoes monitoring.
Guidelines for the management of pediatric TBI [6] suggest
placement of an ICP monitor for severe TBI, despite a lack of
evidence. Our study is comparable to previous studies in pe-
diatrics and confirms low use of ICP monitoring in children.
This is the first study to explore the reasons for lack of ICP
monitoring in the pediatric population. Our results suggest
that there may frequently be a clinical justification for low
rates of ICP placement. The decision not to monitor ICP often
weighs clinical risks and benefits; it is perhaps too invasive
and risky in patients with improving GCS and is futile in
moribund patients with catastrophic brain injury. The chal-
lenge relies in the clinical judgment of assessing patients
whose clinical assessment at the time of presentation warrants
ICP monitoring. Failure to monitor ICP may have adverse
neurological impacts; however, blindly applying protocol
may result in unnecessary risks in many patients.
Head imaging likely influences the decision to place an
ICP monitor. Recent pediatric model taking into account
GCS, Rotterdam score, mechanism of injury, and severity
score proved to be accurate for prediction mortality risk strat-
ification in pediatrics [12]. Our results support the link be-
tween GCS, reassuring tomography score and decision not
to undergo ICP monitoring. Although the observational de-
sign of the study prevents us from evaluating the accurateness
of this practice, we speculate that this seems reasonable, given
adult guidelines which take head imaging into account in their
management algorithms [5].
Of the patients who underwent ICP monitoring, five had
their monitors placed over 6 h after their arrival to the emer-
gency department, suggesting that they were initially man-
aged with clinical surveillance and failed to improve, requir-
ing the placement of an ICP monitor. This underlines the need
for continual clinical reassessment of the severely brain-
injured patient but also highlights the possible risks asso-
ciated with delayed ICP placement. We can hypothesize
that the patients who were managed with clinical surveil-
lance and never underwent ICP monitoring, likely would
not have benefited from monitoring, as all had a favorable
outcome.
Greater standardization is needed in the management of
children with severe TBI, and efforts should be made to better
understand why practice varies. This study suggests that
reassuring head CT and stable clinical exam frequently leads
to clinical surveillance in our center, with no evident adverse
event. Further research is needed to ascertain if imaging could
safely be considered in the guidelines and management of
these patients.
Conflict of interest All authors have no conflicts of interest to report.
Ethical standard statement Study was conducted with ethics board
approval and met highest ethical standards.
Table 2 Rotterdam CT imaging score of patients initially managed
with clinical surveillance (N=14)
Score, associated mortality





Score 1, 0 % 1 0
Score 2, 7 % 8 2
Score 3, 16 % 0 3
Score 4, 26 % 0 0
Score 5, 53 % 0 0
Score 6, 61 % 0 0
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Rationale: Minimizing exposure of children to blood products is
desirable.
Objectives: We aimed to understand anemia development, blood
loss, and red blood cell (RBC) transfusions in the pediatric intensive
care unit (PICU).
Methods: Prospective, multicenter, 6-month observational study in
30PICUs.Datawerecollectedonconsecutivechildren (,18yrold) in
the PICU for 48 hours or more.
Measurements and Main Results: Anemia development, blood loss,
and RBC transfusions were measured. A total of 977 children were
enrolled. Most (74%) children were anemic in the PICU (33% on
admission,41%developedanemia).Blooddrawsaccounted for73%
ofdailyblood loss;median losswas 5.0ml/day. Forty-ninepercentof
children received transfusions; 74% of first transfusions were on
Days 1–2. After adjusting for age and illness severity, comparedwith
nontransfused children, children who underwent transfusion had
significantly longer days ofmechanical ventilation (2.1 d, P, 0.001)
and PICU stay (1.8 d, P 5 0.03), and had increased mortality (odds
ratio [OR], 11.6; 95% confidence interval [CI], 1.43–90.9; P 5 0.02),
nosocomial infections (OR, 1.9; 95% CI, 1.2–3.0; P 5 0.004), and
cardiorespiratory dysfunction (OR, 2.1; 95% CI, 1.5–3.0; P, 0.001).
High blood loss per kilogram body weight from blood draws (OR,
1.11; 95%CI, 1.03–1.2;P50.01)wasassociatedwithRBCtransfusion
more than 48 hours after admission. The most common indication
for transfusion was low hemoglobin (42%). Pretransfusion hemo-
globin values varied greatly (mean, 9.76 2.7 g/dl).
Conclusions: Critically ill childrenare at significant risk for developing
anemia and receiving blood transfusions. Transfusion in the PICU
was associated with worse outcomes. It is imperative to minimize
blood loss from blood draws and to set clear transfusion thresholds.
Keywords: blood loss; anemia; transfusions; pediatric; intensive care;
red blood cells
Anemia is common in critically ill children admitted to the pe-
diatric intensive care unit (PICU) (1). There are numerous
possible causes for the anemia of critical illness, including chronic
anemia, overt and occult blood loss (2), underlying disease and
treatments causing bone marrow suppression. An inadequate
erythropoietin response to anemia in critically ill patients is
described in adults (3–5) as well as in children (1). However,
there are no data available on blood loss in children admitted to
the PICU.
Red blood cell (RBC) transfusions are a common therapy in
critically ill and injured children. There are multiple risks asso-
ciated with RBC transfusions, including transfusion-transmitted
infections, transfusion-related acute lung injury, hemodynamic
compromise, intravascular volume overload, acute hemolysis,
and immunosuppression (6–9). In adults, RBC transfusions have
also been associated with prolongation of mechanical ventilation
(10), diminished organ function, and even death (11, 12). To date,
nomulticenter prospective data onanemia and transfusions in the
PICU are available.
In this study, we focused on children with a longer PICU stay
who could most benefit from PICU interventions such as blood
conservation protocols or erythropoietin therapy. Children with
a PICU stay greater than 48 hours represent approximately
20% of PICU admissions, but account for disproportionately
high PICU resource utilization (13). We aimed to prospectively
assess the epidemiology of anemia and red cell transfusions in
this population as well as to determine the causes of blood loss
in the PICU. Outcomes and complications were captured to
assess any association with transfusions.
METHODS
This was a prospective, multicenter, epidemiologic, observational study
conducted in 30 PICUs of the Pediatric Acute Lung Injury and Sepsis
Investigators (PALISI) Network in the United States and Canada from
September 8, 2004, toMarch 29, 2005. All consecutive children, younger
than 18 years, admitted for any reason were eligible for study enrollment
once remaining in the PICU for more than 48 hours (see the online
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supplement for information on children with PICU stay < 48 h).
Exclusion criteria included the following: prematureneonates (corrected
gestational age< 37wk and age, 28 d), prior participation in the survey,
family history of refusing blood transfusions, involvement in other
transfusion or bloodmanagement–related research, pregnancy, impend-
ing brain death, and recent (within 7 d) PICU stay ofmore than 72 hours.
Enrollment in the study continued until the predefined sample size
(z1,000 children with length of stay . 48 h) had been reached. The
survey did not require additional interventions/procedures that were not
part of routinemedical practice. The institutional reviewboardapproved
the study at each site. Written, informed consent was obtained for all
enrolled subjects.
All blood loss information was collected prospectively on all chil-
dren from admission onward. Other data from the first 48 hours after
admission were collected retrospectively. All data after 48 hours of
admission were collected prospectively. The number of blood draws
and volume of each draw were recorded by the bedside nurse and
collected for all children each day the patient remained in the PICU. A
day was defined as a calendar day starting at midnight. Data were
collected for all participants for a maximum of 28 days total or until
hospital discharge, interinstitutional transfer, or death. Children read-
mitted to the PICU less than 48 hours after transfer were regarded as
still in the PICU.
Data collected on admission included the following: demographics,
severity of illness using the Pediatric Risk of Mortality (PRISM) III
score (14), organ dysfunction using Pediatric Logistic Organ Dysfunc-
tion (PELOD) score (15), and multiple organ dysfunction score (MODS)
(16). Daily data collection included lowest daily hemoglobin (Hb)
level, RBC transfusion events, reason for physician ordering trans-
fusion, blood loss from blood draws, PELOD and MODS variables,
and clinical events including mechanical ventilation, specific technol-
ogies, surgery, or complications. Anemia was defined as an Hb con-
centration 2 SD below the mean Hb concentration for each age group.
The cutoff values to determine anemia were as follows: 14.5 g/dl for
neonates, dropping to 9 g/dl at 2 months of age, then rising to 10.5 g/dl
at 6 months of age, 11.5 g/dl at 2 years of age, and 12 g/dl in females and
13 g/dl in males at adolescence (17). The following categories of
severity of anemia were created for subsequent analysis to assess the
impact on degree of anemia: ‘‘severe anemia,’’ an Hb of less than 7.0 g/
dl; ‘‘moderate anemia,’’ an Hb greater than 7.0 and less than 10.0 g/dl;
and ‘‘mild anemia,’’ anemia and an Hb greater than 10 g/dl.
Chi-square tests were used to make unadjusted bivariate tests of as-
sociation between the outcomes and categorical predictors. For contin-
uous predictors, Student’s t tests were used. Children with anemia on
admission to the PICU, children who became anemic during their PICU
stay, and children who were never anemic were compared with analysis
of variance. The relationship between complications and transfusion on
Day 1 or 2 was examined by comparing the complications on Day 3 or
later in two groups: (1) those with one ormore transfusions onDay 1 or 2
(n5 363) and (2) those with no transfusions during their PICU stay (n5
494). Logistic regression, adjusted for age and admission PRISM III
score, was used to compare odds of complication for the subjects who did
or did not undergo transfusion. Logistic regression was also used to
model risk for developing anemia and risk for receiving a transfusion.
Separate regression models were computed for each outcome. In each
case, a backward variable selection procedure was used to eliminate
predictors not significantly associatedwith the outcomes.Determination
of clinical risk factors for the logistic regression models—(1) developing
anemia after Day 2 and (2) getting a transfusion after Day 2—were
calculated. Children receiving extracorporeal membranous oxygenation
(ECMO) on Day 1 or 2 (n5 19) were excluded from regression models
(SAS version 9.1; SAS Institute, Cary, NC). Median Hb for the trans-
fused and nontransfused groups was compared by ranking Hb levels, by
day, for the two transfusion groups combined and using a generalized
estimating equations regression model (SAS Proc Genmod; SAS In-
stitute) to test for a main effect of transfusion group.
RESULTS
Children were enrolled from moderate- to large-sized PICUs
(70% in children’s hospitals and 60% in academic centers) in
the United States (25 sites, at least 1 from each U.S. Census
region) and Canada (5 sites from 4 regions). Table E1 (see the
online supplement) details enrollment by census region. The
median number of PICU beds was 20 (range, 8–67).
There were 5,570 admissions during the study period; 1,097
(19.7%) remained in the PICU for more than 48 hours. Of these,
986 were enrolled (consent rate, 89.9%). There were nine in-
complete case report forms (0.7%) from one study site, leaving
977 children for analysis. Baseline demographic characteristics of
these children are presented in Table 1 together with baseline
data on anemic children, childrenwho received a transfusion, and
those that developed anemia or received a late transfusion.
In the youngest age category (<28 d), 63% of patients were
primarily admitted as surgical nontrauma, whereas in the three
oldest age groups, the highest proportion of children were ad-
mitted as medical nontrauma. Children in the age category
ranging from 28 days to less than 2 years were equally distributed
between these two admission types. The most common primary
PICU admitting diagnostic category for children younger than 28
days was the cardiovascular system (n 5 62 [75%]). In contrast,
the respiratory systemwasmost common among the threemiddle
age categories (38–42% of children). In the oldest age group, the
respiratory and central nervous systems were the most common
admitting diagnostic categories (32 and 34% of children, respec-
tively). There was an increasing trend with age in the proportion
of children whose primary PICU admitting diagnostic category
was the central nervous system.
Anemia
A history of anemia within 7 days before PICU admission was
reported in 15% of children. Anemia in the PICU was common:
it was present on admission in 33% of children. An additional
41% became anemic during their PICU stay. Only 26% of the
children never became anemic. Anemia overall (either on
admission or during PICU stay) was more common in neonates
and adolescents (Figure 1) (P , 0.0001).
Children with anemia on admission to the PICU had a higher
severity of illness score with higher PRISM III (mean, 5.36 5.8)
than children who became anemic during their PICU stay (mean,
3.86 5.1) and children who were never anemic (mean, 3.36 4.5)
(P , 0.0001). There was no difference in the amount of average
daily blood loss from all sources among these three groups. The
PICU length of stay was greatest in the group who developed
anemia in the PICU (mean, 10.4 6 7.8 d) compared with those
anemic on admission (8.9 6 7.0 d) or never anemic (6.6 6 5.9 d)
(P, 0.0001). In addition, children who developed anemia in the
PICUhadmore days ofmechanical ventilation (mean, 6.7 d) than
those anemic on admission (5.7 d) or never anemic (2.7 d) (P ,
0.0001).
A multivariate logistic regression model was used to identify
independent risk factors fore children developing anemia more
than 48 hours after admission. Children were excluded if they
were receiving ECMO or if they had anemia on admission or
anemia on Days 1–2 (438 children were left for analysis; 176
developed anemia). Factors predictive of anemia development in
the univariate analyses were tested in themultivariate model and
are reported in Table 2. Significant predictors of initial anemia
development more than 48 hours after PICU admission were age
of 28 days or younger, no RBC transfusion on PICU Days 1–2,
presence of shock on PICU admission, admission category of
‘‘other’’ (gastrointestinal, endocrine, renal, hematology/oncol-
ogy), baseline PELOD score of 11 or more, and having a re-
spiratory comorbid condition. Factors not predictive of develop-
ing later anemia in the bivariate analysis were transfusion before
admission, sex, race, admission type (medical, surgical non-
trauma, trauma), PRISM III score (0, 1–5, >6), and blood loss/
kg from blood draws on admission for Days 1–2.
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Blood Loss
Almost all children (96.5%) had blood loss fromblood draws, 325
(33%) had some blood loss due to procedures (median daily loss
was 0.25ml/kg), and 233 (24%)hadblood loss due to spontaneous
bleeding (median daily loss was 2.56 ml/kg). Blood loss from
blood draws accounted for the majority of total blood loss during
the ICU stay in all age groups (mean, 72.9%; median, 100%).
Children who had either an arterial line or a central venous
catheter in place during the PICU stay had a 2.3- to 4-times higher
median number of blood draws per day through Day 14 of their
PICU stay than children with peripheral venous lines only.
The mean volume of blood loss per blood draw was 2.7 6
2.3 ml/draw (median, 2.0 ml/draw). There were a mean of three
blood draws/day with amean daily volume of blood loss of 8.256
21.5 ml/day (median, 5.0 ml/d; adjusted for weight, 0.32 ml/kg/d).
An analysis of daily blood loss from blood draws by age category
adjusted for weight (kg) shows an inverse relationship between
blood loss/kg and age (P5 0.02) (Figure 2). For all children, there
was a decreasing trend in themedian number of daily blooddraws
per patient over time during the PICU stay, with the highest
number of blooddraws per patient (mean, 7;median, 6) occurring
on the second calendar day of admission.
RBC Transfusion
Overall, 475 (49%) children received one or more RBC trans-
fusions during the PICU stay and 6% received a transfusion after
PICU discharge. The first transfusion was given within 48 hours
of PICU admission 74% of the time (22% received their first
transfusion between Days 2 and 7, and only 4% received their
first transfusion . 7 d after admission to PICU). One hundred
eighty-one (38%) children who received a transfusion had only
one transfusion, whereas 110 (23%) had two, 50 (11%) had three,
and 34 (7%) had four transfusions. The remaining 100 (21%) had
four or more transfusions, and this group received 1,017 (50%)
of all transfusion events. The time course of transfusions is






.48 h after Admit, n (%)
Any Transfusion
in PICU, n (%)
Transfusion .48 h
after Admit, n (%)
(n 5 977) (n 5 322) (n 5 176) (n 5 475) (n 5 162)
Age group
,28 d 83 (8) 28 (9) 23 (13) 58 (12) 26 (16)
>28 d to ,2 yr 358 (37) 82 (25) 72 (41) 208 (44) 63 (39)
>2 yr to ,5 yr 137 (14) 38 (12) 28 (16) 57 (12) 19 (12)
>5 yr to ,12 yr 183 (19) 72 (22) 28 (16) 67 (14) 24 (15)
>12 yr to ,18 yr 216 (22) 102 (32) 25 (14) 85 (18) 30 (19)
Male sex 575 (59) 203 (63) 102 (58) 276 (58) 88 (54)
Admitting type
Trauma 99 (10) 50 (16) 11 (6) 56 (12) 15 (9)
Surgical, nontrauma 383 (39) 106 (33) 75 (43) 216 (45) 53 (33)
Medical, nontrauma 495 (51) 166 (52) 90 (51) 203 (43) 94 (58)
Admitting category
Cardiovascular system 253 (26) 58 (18) 50 (28) 187 (39) 53 (33)
Nervous system 217 (22) 82 (26) 34 (19) 79 (17) 24 (15)
Digestive system 62 (6) 29 (9) 17 (10) 40 (8) 14 (9)
Endocrine system 17 (2) 3 (1) 4 (2) 6 (1) 4 (3)
Hematologic 39 (4) 27 (8) 1 (1) 31 (7) 9 (6)
Renal/urologic 22 (2) 14 (4) 3 (2) 16 (3) 4 (3)
Respiratory 353 (36) 102 (32) 66 (37) 111 (23) 53 (33)
Comorbid conditions*
None 387 (40) 127 (39) 69 (39) 185 (39) 58 (36)
Asthma 112 (12) 37 (11) 17 (10) 36 (8) 13 (8)
Cyanotic congenital heart disease 136 (14) 25 (8) 34 (19) 110 (23) 33 (20)
Nervous system 199 (20) 65 (20) 38 (22) 66 (14) 27 (17)
Renal and urologic 80 (8) 34 (11) 14 (8) 44 (9) 12 (7)
Other 128 (13) 46 (15) 18 (10) 73 (16) 19 (12)
PRISM III score
Mean (SD) 4.2 (5.3) 5.3 (5.8) 3.6 (4.5) 5.6 (5.8) 4.5 (5.1)
Median 2.0 4.0 2.0 4.0 3.0
Definition of abbreviations: MODS 5 multisystem organ dysfunction score; PELOD 5 Pediatric Logistic Organ Dysfunction; PICU 5 pediatric intensive care unit;
PRISM 5 Pediatric Risk of Mortality.
* A patient can present with more than one comorbid condition.
Figure 1. Proportion of patients with anemia overall (patients with
anemia on admission coupled with those that developed anemia in the
pediatric intensive care unit [PICU]) and of patients who received at
least one red blood cell transfusion during their PICU stay. *Groups
were statistically different by age (P , 0.0001).
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presented in Figure 3, which shows the predominance of early
transfusions. Transfusion-related complications of fever, hemo-
lysis, or transfusion reaction were rare at 0.5%.
Data on packed RBC (PRBC) characteristics were available
for 1,301 transfusions that occurred in the PICUafter enrollment.
This revealed that 69% of these PICU transfusions were with
irradiatedblood, 92%were fromunrelateddonors, and86%were
leukocyte depleted. The storage age of the blood was recorded in
1,288 transfusions. Sixty-five percent (842) of the PRBCs given
were less than or equal to 14 days of storage. Themean age of the
blood, when recorded, was 13.3 days.
Compared with the subset of children who did not receive
a transfusion during the PICU stay, the children who received
a transfusion in the PICU were younger (mean age, 4.5 vs. 6.6 yr;
P, 0.001), had a higher rate of anemia on admission (44 vs. 22%,
P, 0.001), and had higher baseline PRISM III score (P, 0.001).
Transfusion incidence by age is presented in Figure 1. Children
who received at least one RBC transfusion during their PICU
stay also had a greater average daily blood loss (median, 1.6 vs.
0.2ml/kg;P, 0.001), a higher incidenceof anemia (24 vs. 7%,P,
0.001) and transfusions (41 vs. 2%,P, 0.001)within 7 days before
PICU admission, more surgical/invasive procedures at PICU
admission (47 vs. 38%, P5 0.003), and more shock on admission
(21 vs. 6%, P , 0.001). Most of the children who had a primary
admitting diagnosis pertaining to the cardiovascular system
received a transfusion during the PICU stay (74%).
A total of 3,521 predefined complications were documented
during the PICU stay. The effect of transfusion on outcomes
was evaluated by comparing PICU complications that occurred
after 48 hours in those children who had received a transfusion
on Day 1 or 2 (n 5 363) with those who never received a
transfusion (n5 494) during their PICU stay. Correcting for age
and for admitting PRISM III scores, the transfused group had
an increased risk of death (odds ratio [OR], 11.6; 95% confi-
dence interval [CI], 1.43–90.9; P 5 0.02), an increased risk of
death and/or cardiac arrest (OR, 20.0; 95% CI, 2.6–166.7; P 5
0.004), a higher rate of nosocomial infections (OR, 1.9; 95% CI,
1.2–3.0; P 5 0.004), and more cardiac or respiratory dysfunction
(OR, 2.1; 95% CI, 1.5–3.0; P, 0.001). The transfused group had
a longer PICU length of stay (7.5 d in nontransfused vs. 9.3 d in
transfused, P 5 0.0002) and, for children ventilated beyond 48
hours (n5 421 [204 nontransfused and 217 transfused]), a longer
length of mechanical ventilation (7.5 d in nontransfused vs. 9.6 d
in transfused, P 5 0.003). Of note, 12 of 15 deaths (80%) in the
transfused group occurred in patients who had received more than
four transfusions in the PICU.
The number of patients who received a transfusion after 48
hourswas 162 (17%). Predictors for receiving anRBCtransfusion
after the first 2 days in the PICU were calculated using a multi-
variate logistic regression analysis, excluding only those children
receiving ECMO on PICUDays 1–2 (n5 19). Factors predictive
of a later transfusion in the bivariate analysis were tested in the
multivariate model and are reported in Table 3. Significant
predictors of receiving a transfusion more than 48 hours after
PICUadmissionwere age of 28 days or younger,RBC transfusion
Figure 2. Average num-
ber of blood draws per
day per patient and aver-
age volume of blood col-
lected per day per patient
by age of patients.
*Groups were statistically
different by age (P ,
0.02).
Figure 3. Cumulative distribution of day of transfusion for children
with one, two, and three total transfusions.
TABLE 2. PREDICTORS OF DEVELOPMENT OF ANEMIA AFTER
PEDIATRIC INTENSIVE CARE UNIT DAY 2 (n 5 438)*
Effect
Odds Ratio (95% Wald
confidence limits) P Value
Age category
,28 d 4.9 (1.8–13.4)
>28 d to ,2 yr 0.9 (0.4–1.6)
>2 yr to ,5 yr 1.1 (0.5–2.3)
>5 yr to ,12 yr Reference
>12 yr to <18 yr 1.2 (0.5–2.6) ,0.01





Other 1.1 (0.6–2.0) 0.38
No transfusion ICU Days 1–2 2.6 (1.4–4.8) ,0.01
Absence of shock on admission 0.4 (0.2–1.0) 0.04
Primary admission category
Respiratory Reference
Cardiovascular system 0.7 (0.4–1.3)
Central nervous system 0.9 (0.5–1.7)








Definition of abbreviation: PELOD 5 Pediatric Logistic Organ Dysfunction.
* Children on extracorporeal membranous oxygenation Days 1–2, anemic on
admission, or anemic on Days 1–2 were excluded (n 5 539).
† Other included gastrointestinal, hematology, endocrine, or renal.
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on PICU Days 1 or 2, presence of severe or moderate anemia,
presence of shock on PICU admission, admission because of
trauma, admission category of cardiovascular or ‘‘other,’’ base-
line PRISM III score of more than 5, having a hematologic/
oncologic comorbid condition, and high mean daily volume/kg of
blood loss from blood draws. Factors not predictive in the
univariate analysis were sex, race, and admission type (medical,
surgical nontrauma, trauma).
The reason for transfusion in the PICU was reported by the
prescribing physician and is presented in Table 4. LowHbwas the
most common reason listed (42%), and this category had
a significantly lower mean pretransfusion Hb than the other
groups (P , 0.001). Bone marrow suppression and specific tech-
nologies were infrequent primary reasons for transfusion, but
those patients had many more transfusion events per patient.
Mean number of PICU transfusions varied significantly between
reason groups (P , 0.0001).
There was marked variability in Hb values before trans-
fusion. Table 5 shows the mean and median pretransfusion Hb
plus intraquartile ranges for the first transfusion by age, ad-
mitting type (medical vs. surgical/trauma), and severity of ill-
ness (PRISM III score). Younger children had a higher mean
pretransfusion Hgb (P , 0.0001). Children with a lower PRISM
III score (<5) and a medical admission type had lower pre-
transfusion Hb levels (P , 0.001).
Median daily Hb values were lower for children who re-
ceived a transfusion compared with those who did not (P ,
0.0001; Figure 4). Excluding neonates, Hb values for 75% of
children for the first 14 days of ICU stay were 8.4 g/dl or greater
in those who did not receive a transfusion and 8.1 g/dl or more
in those who received one or more PRBC transfusion.
DISCUSSION
This is the first large, multicenter, prospective study of anemia,
blood loss, and transfusion practices in critically ill children.
Anemia was a common problem, affecting 74% of these chil-
dren during or immediately before PICU admission. Blood loss
via blood draws was particularly significant in the younger age
groups. Almost half of the study population received at least
one RBC transfusion. The majority (74%) received their first
transfusion in the first 2 days after admission and only 4%
received it after the first week. These data provide evidence
TABLE 3. PREDICTORS OF TRANSFUSION AFTER PEDIATRIC
INTENSIVE CARE UNIT DAY 2 (n 5 958)*
Effect
Odds Ratio (95% Wald
confidence limits) P Value
Age category
,28 d 2.4 (1.2–5.1)
>28 d to ,2 yr 1.3 (0.8–2.0)
>2 yr to ,5 yr 0.8 (0.5–1.5)
>5 yr to ,12 yr Reference
>12 yr to <18 yr 0.8 (0.5–1.3) 0.03





Other 0.6 (0.4–1.0) 0.09
No transfusion ICU Days 1–2 0.5 (0.4–0.8) ,0.001
Anemia severity
Severe (Hb , 7g/dl) 7.5 (3.5–15.7)
Moderate (Hb . 7 and ,10 g/dl) 2.0 (1.4–2.8)
Mild (Hb . 10 g/dl) Reference ,0.001
Primary admitting type
Medical 0.7 (0.3–1.3)





Central nervous system 0.8 (0.5–1.4)






Hematology/oncology comorbidity 1.8 (1.1–3.1) 0.02
Blood loss via blood draws
Above mean daily volume/kg loss 1.1 (1.0–1.2) 0.01
Definition of abbreviations: Hb 5 hemoglobin; ICU 5 intensive care unit; PRISM
5 Pediatric Risk of Mortality.
* Children on extracorporeal membranous oxygenation Days 1–2 were
excluded (n 5 19).
† Other included gastrointestinal, hematology, endocrine, or renal.
TABLE 4. REASON FOR FIRST TRANSFUSION BY ORDERING










Low hemoglobin 198 (42) 3.1 (3.5) [2.0] 8.2 (2.4) [7.9]
Unknown 80 (17) 1.8 (2.1) [1.0] 10.4 (3.0) [9.9]
Acute blood loss (gastrointestinal
bleeding/surgical procedures*)
78 (16) 4.8 (6.2) [2.0] 10.5 (2.5) [10.6]
Cardiovascular insufficiency† 41 (9) 3.6 (3.3) [2.0] 10.4 (2.3) [10.0]
Specific technologies‡ 35 (7) 10.9 (8.2) [10.0] 10.7 (3.1) [10.3]
Respiratory insufficiencyx 34 (7) 2.9 (1.9) [2.0] 9.6 (2.2) [9.5]
Bone marrow
suppression/coagulopathy
9 (2) 5.2 (5.4) [3.0] 8.8 (1.4) [9.4]
Definition of abbreviation: PICU 5 pediatric intensive care unit.
Data from ordering physician first-ranked indication. Mean number of PICU
transfusions varied significantly between transfusion reason groups (P , 0.0001).
Mean pretransfusion hemoglobin significantly lower in the low hemoglobin
group (P , 0.001).
* Surgical procedures: elective or emergent surgery, trauma.
† Cardiovascular: cardiac dysfunction, hypotension, cyanotic heart disease.
‡ Specific technologies: extracorporeal membranous oxygenation, hemodialysis,
plasmaphoresis, hemofiltration, exchange transfusion.
x Respiratory: enhanced oxygen delivery, low PaO2, respiratory insufficiency.







Overall 451 9.7 (2.7) 9.2 (7.7–11.4)
Age
,28 d 56 (12) 12.3 (2.3) [22.2] 12.5 (10.4–14.2)
>28 d to ,2 yr 193 (43) 9.8 (2.6) [21.1] 9.2 (7.8–11.6)
>2 yr to ,5 yr 55 (12) 9.7 (2.8) [21.6] 9.0 (7.5–11.3)
>5 yr to 12 yr 66 (15) 8.8 (1.9) [21.6] 8.3 (7.6–10.0)
>12 yr to ,18 yr 81 (18) 8.7 (2.4) [23.9] 8.2 (7.0–9.8) ,0.001
Admission type
Medical 195 (43) 8.7 (2.0) 8.2 (7.2–10.0)
Nonmedical† 256 (57) 10.6 (2.8) 10.3 (8.4–12.7) ,0.001
Severity of illness
PRISM III <5 253 (56) 9.2 (2.4) 8.8 (7.5–10.5)
PRISM III .5 198 (44) 10.4 (2.8) 10.0 (8–12.7) ,0.001
Definition of abbreviations: IQR 5 25–75% intraquartile range; PRISM 5
Pediatric Risk of Mortality.
* DChange from anemia cutoff: difference of mean pretransfusion hemoglobin
from cutoff for definition of anemia for that age group.
† Nonmedical: elective or emergent surgical admission or trauma.
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against prophylactic therapy with erythropoietin to prevent
blood transfusions in the PICU setting, and focus more empha-
sis on blood loss prevention. After correction for age and illness
severity, the increased length of stay and complications shown
in the children who received a transfusion provide supportive evi-
dence that efforts at minimizing transfusions should continue.
Most data available on incidence of anemia and transfusion
practices in the children come from neonates, which do not
provide clear guidance for the highly variable PICU population
(18–20). Anemia in critically ill children is almost always treated
by blood transfusion, and transfusions have been associated
with increased PICU utilization (21). Published reports suggest
considerable variability in practice. A single-center Canadian
study revealed that 15% of all children in the ICU received at
least one transfusion (22), whereas a British single-center study
reported that 48% of all children in the PICU received at least
one transfusion (23). Surveys of physician opinion suggest wide
variability of Hb values used to justify RBC transfusion de-
cisions in children (24–26). Our multicenter international study
showed that the proportion of children who received at least
one RBC transfusion while they were in the PICU was 49%.
The rate of anemia observed in our study population was
higher than expected. These data mimic the results reported on
adults by Vincent and colleagues in their prospective blood loss
and transfusion survey in European ICUs, with similar rates of
anemia on admission (33 vs. 36%) (11). However, the preva-
lence of anemia in the PICU is greater due to the additional
41% who developed anemia in the PICU.
The impact of anemia on the outcome of critically ill children
is not well understood. Some data suggest that severe anemia
may be detrimental to critically ill children with septic shock or
hemodynamic compromise (27–30). Anemia was associated
with a worse outcome in the Corwin study, a descriptive pro-
spective study that included 4,892 consecutive critically ill adults
from 213 American ICUs (31). The same association was
observed in 3,534 adults from 146 Europeans ICUs (11). The
postoperative risk of death increases significantly when Hb
concentration drops below 4 g/dl (32). Three prospective studies
run in Kenya involving, respectively, 2,433, 1,223, and 1,269
hospitalized children showed that the risk of death was signif-
icantly higher if their Hb concentration was lower than 5 g/dl
and if they did not receive an RBC transfusion; these children
were not critically ill, but most had respiratory symptoms (33–
35). Therefore, severe anemia seems to be an independent risk
factor for death in sick patients, at least when the Hb concentra-
tion drops below 5 g/dl. On the other hand, a large multicenter
randomized clinical trial, the TRIPICU (Transfusion Require-
ments in the Pediatric Intensive Care Unit) study, showed that
a restrictive RBC transfusion strategy in which the threshold
Hb concentration to prescribe a transfusion was 7 g/dl was not
inferior to a liberal strategy with a threshold of 9.5 g/dl in stable,
critically ill children (36). This suggests that an RBC transfusion
is probably not useful in stable children if their Hb concentra-
tion is above 7 g/dl. The Hb concentration that should prompt
pediatric intensivists to prescribe an RBC transfusion in un-
stable children remains to be determined. Higher Hb concen-
trations may be required in children with greater severity of
illness (e.g., shock) and in specific subpopulations (e.g., post-
operative cardiac surgery).
Small body size and small total blood volume make children
vulnerable to anemia secondary to blood draws despite the use
of microsampling techniques. Our findings point out the need
for future studies of blood conservation strategies via phlebot-
omy in the PICU. The median blood volume loss was 5.0 ml/day
in our study, which is markedly less than the 41 ml/day reported
by Vincent and colleagues in adult ICUs (11). However, the
degree of blood volume loss remains significant, particularly
because almost half of our population was younger than
24 months. The total blood volume of a 5-kg child is about
400 ml in comparison to 5 L in a typical adult. Younger children
have higher circulating blood volumes per kilogram (80 ml/kg)
than older children and adults (70 ml/kg) (37), but the burden
on them from iatrogenic blood loss remains significantly higher
due to their overall lower blood volumes. Blood loss was not
predictive of later anemia, most likely because such a high
percentage of patients were anemic (74%) and our model did
not determine whether blood draws led to more severe anemia.
More importantly, we noted that blood loss secondary to blood
draws early in admission was predictive of later transfusion.
Vincent and coworkers reported a transfusion rate of 34% in
their adult trial. Our findings of a 49% transfusion rate are
higher, potentially due to a different transfusion threshold
practiced in the PICU. The mean pretransfusion Hb in the
adult trial was 8.46 1.3 g/dl compared with our findings of 9.76
2.7 g/dl (11). The results of the TRIPICU study suggest that it is
safe not to give RBC transfusion to stable, critically ill children
if their Hb concentration is higher than 7 g/dl (35). In our study,
the children who could be considered more stable (based on low
PRISM III scores , 5) and who received a transfusion (n 5
253) had a mean pretransfusion Hb of 9.23 6 2.4 g/dl. Markedly
fewer children in these groups might receive a transfusion if the
results of the TRIPICU study are applied.
Almost three-quarters of our patients received their transfu-
sions in the first 2 days. Unless the criteria for RBC transfusion
changes, it is unlikely that therapies such as erythropoietin will
be of benefit to prevent transfusions given the time required for
this therapy to affect a change in Hb in critically ill patients (38).
The use of erythropoietin in the PICU may merit further study,
however, because of recent evidence demonstrating a mortality
benefit in critically ill adults, which was independent of its effect
on Hb (39).
This study represents the largest assessment of the RBC
transfusion rationale among physicians caring for critically ill
patients. Low Hb was almost twice as common as blood loss as
the primary reason for transfusion. Therefore, clearer guide-
lines for Hb values that should trigger a transfusion would
benefit clinicians. On the other hand, our data suggest that some
attention must also be paid to other justifications, such as the
severity of illness and blood loss.
Figure 4. Median hemoglobin by day and transfusion group (age . 2
and , 18 yr). Mean daily hemoglobin for the first 14 days was
significantly less in patients who received a transfusion (P , 0.001).
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The strengths of our study include the size of the study
population, and the focus on the relationship between PICU
day and transfusion risk. We noted that those children staying in
the PICU more than 48 hours are at higher risk for transfusion.
The proportion of children who received an RBC transfusion
was 17% in 216 children who stayed in the PICU less than
2 days in comparison to 49% in the 977 who stayed more than
48 hours (see Table E2). The generalizability to the entire PICU
population must account for the fact that only approximately
20% of PICU patients have a length of stay greater than 48 hours.
In this long-stay population, our data show that, when cor-
rected for severity of illness, transfusions were associated with
significantly worse outcomes. This has not been shown previously
in any prospective study in the PICU and warrants a serious look
into the use of transfusions in this population. Our data are
consistent with the adult literature byVincent and colleagues and
Corwin and coworkers, which also showed longer length of stay
and increased morbidity and mortality in the transfused ICU
patients (11, 31).However, thiswas contrasted by themore recent
analysis of adult ICU patients, which showed no mortality
increase in patients who received a transfusion (40). This dis-
crepancy has been suggested to be due to PRBC factors such as
leukoreduction and older age of blood. The storage age of blood
of greater than 2 weeks was reported to be an independent risk
factor of mortality in adult cardiac surgical patients (41). Our
findings of worse outcomes in the PICU children who received
a transfusion, however, were with blood that had an 86%
leukoreduction rate and 65% with storage age less than 14 days.
Therefore, the effect of transfusion in our population appears to
be independent of the suspected PRBC factors. A single-center
retrospective study of transfusions in critically ill children by
Kneyber and colleagues also found increased mortality and
morbidity in children who received a transfusion, and all of their
transfusions were with leukoreduced blood (42). The finding that
a majority of the deaths in this study occurred in patients with
more than four transfusions raises the need to better understand
the effects of transfusion in unstable children. There was no
increased death rate in the children who received a single or
double transfusions. We did confirm the findings of Slonim and
coworkers that complications directly related to the administra-
tion of PRBCs in children are rare (43).
In conclusion, the burden of anemia, blood loss, and trans-
fusions in the PICU population are significant. Efforts to develop
guidelines are clearly needed. Prospective studies taking into
account the data provided in this largemulticenter epidemiologic
study should be undertaken to estimate the clinical impact of
measures aiming to decrease blood draws, to prevent or treat
anemia, and to decrease transfusions for critically ill children.
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1. LA NÉCESSITÉ DE RÉALISER UN ESSAI  
1.1 Le problème sur lequel portera l'essai 
Les accidents sont la première cause de décès chez les enfants âgés de 1 à 16ans1, et la 
première cause de décès parmi eux est le traumatisme crânien sévère. La sévérité du 
traumatisme crânien est typiquement évaluée par un score clinique, le Score de Glascow,  
qui évalue la réponse motrice, verbale et oculaire du patient2. Le traumatisme crânien 
(TCC) sévère se définit par un Score de Glasgow <8 et nécessite une prise en charge 
agressive vu la haute mortalité qui y est associée. La prise en charge du traumatisme 
crânien nécessite une évaluation radiologique, une consultation neurologique et un 
contrôle étroit de l’œdème cérébral qui se développe sur les 48-72h après l’évènement.  
Une hypertension intracrânienne (HTIC) se caractérise par une pression intracérébrale 
(PIC) > 20mmHg, mesurée avec un moniteur de pression intracrânienne placé dans le 
tissu cérébral après l’évènement. Une HTIC prolongée est associée à un mauvais 
pronostic sur le plan neurologique et à une mortalité augmentée3. 
Des lignes directrices existent pour la prise en charge du traumatisme cranio-cérébral 
sévère chez l’adulte et chez l’enfant4,5,6. Cette prise en charge inclut le monitoring invasif 
de la pression intracrânienne et l’utilisation d’agents hyperosmolaires : le mannitol et le 
salin hypertonique 3% pour traiter une pression intracrânienne élevée. 
Les principales théories quand au mécanisme d’action du salin et du mannitol sont la 
réduction de la viscosité sanguine de même qu’une réduction de l’eau intracellulaire 
intracérébrale due à un mouvement oncotique d’eau vers le compartiment intravasculaire.  
Les études adultes démontrent un bénéfice sur l’HTIC pour l’utilisation du salin 
hypertonique (7%) par rapport au mannitol7,8, par contre aucune étude ne démontre des 
bénéfices cliniques soutenu à long terme pour l’un ou l’autre9. Aucune donnée 
pédiatrique n’existe quand à la supériorité d’un agent par rapport à l’autre, tant sur la 
diminution de la pression intracrânienne que sur les effets cliniques à long terme. 
Actuellement, l’utilisation du mannitol ou du salin hypertonique pour une PIC élevée 
chez l’enfant se fait de façon relativement aléatoire selon la préférence du médecin 
traitant ou du centre traitant. Bennett et al. ont étudié l’utilisation de ces agents dans une 
étude de base de données rétrospectives, et ont démontré une grande variabilité de 
l’utilisation du salin et du mannitol selon l’âge et le centre de traitement10. Nous 
souhaitons déterminer si un agent hyperosmolaire est supérieur à l’autre pour diminuer la 
pression intracrânienne en phase aigue. 
 
1.2 Principales questions auxquelles la recherche tentera de répondre  
Dans la prise en charge du traumatisme crânien sévère chez l’enfant, y-a-t‘il une 
différence significative entre le salin hypertonique (3%) et le mannitol (20%) sur la 
réduction de la pression intracrânienne dans les deux heures après le traitement? Cette 
différence persiste-elle dans les 4 heures suivantes? 
De plus, quels sont les taux de complications majeures de ces agents hyperosmolaires? 
Lequel est associé à des co-interventions plus importantes? Les complications 
potentielles et problèmes secondaires à chercher dans notre étude seront l’hypotension, 
l’hypernatrémie et l’insuffisance rénale aigue (IRA). 
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1.3 Pourquoi l’essai doit-il être réalisé à ce moment-ci? 
Actuellement, il existe une équipoise clinique quand à l’utilisation des agents 
hyperosmolaires pour la prise en charge de la PIC. Les pratiques hospitalières se basent 
surtout sur le confort du médecin traitant et non sur une science déterminée. Plusieurs 
études adultes ont comparé le salin hypertonique et le mannitol pour la pression 
intracrânienne. Vialet et al, ont comparé deux charges iso volumiques de salin et 
mannitol (4.8 mOsm/kg vs 2.3 mOsm/kg) et ont démontré une supériorité du salin pour la 
réduction de l’hypertension intracrânienne11. Harutjunyan et al. ont démontré une 
supériorité du salin 7,2%/starch par rapport au mannitol 15% pour réduire la pression 
intracrânienne chez les patients adultes de neurochirurgies8. Battison et al. ont comparé 
une solution équimolaire de salin/dextran (110cc) par rapport au mannitol (230cc), et ont 
démontré une diminution plus importante et plus soutenue avec la solution 
salin/dextran12. Francony et al. ont ensuite comparé des doses équimolaires de mannitol 
et salin hypertonique (sans dextran) et n’ont pas trouvé de différence entre les traitements 
sur la diminution de la pression intracrânienne à 60 et 120 minutes7. Il y a  donc 
beaucoup de variabilité quant aux protocoles et aux solutions de traitement des ces 
différentes études. Malgré une tendance pour des meilleurs résultats avec le salin, aucune 
étude n’a démontré un effet clinique bénéfique à long terme. En pédiatrie, aucune étude 
comparant ces deux agents n’a été effectuée pour déterminer leur efficacité sur la 
diminution de la pression intracrânienne, et les deux traitements sont considérés comme 
standard pour la prise en charge de l’HTIC. De plus, les dernières recommandations 
internationales mentionnaient l’absence de données pour comparer les deux agents chez 
l’enfant et encourageaient les recherches dans ce domaine. 
 
1.4 Études systématiques pertinentes et analyse de la nécessité de réaliser l'essai 
proposé  
Mortazavi et al. ont effectué une méta-analyse sur le salin hypertonique dans la réduction 
de l’HTIC chez l’adulte13. Parmi les études publiées, 12 études ont comparé le salin 
hypertonique et le mannitol, et 6 étaient des études randomisées contrôlées (ECR). Les 
études étaient relativement petites (n max =34) et variables quand aux paramètres étudiés 
et aux bolus osmolaires reçus, mais dans l’ensemble neuf d’entre elles ont suggéré une 
supériorité du salin hypertonique et trois n’ont montré aucune différence. Kamel et al. ont 
aussi effectué une méta-analyse incluant 5 ECR comparant les deux traitements et ont 
conclu à une supériorité du salin hypertonique pour une diminution de la pression 
intracrânienne14. Aucune des ces études n’a été effectuée sur une population pédiatrique, 
et il n’y a aucun RCT dans ce domaine en pédiatrie. 
1.5 Quelle utilisation sera faite des résultats de l’essai ?  
Cette étude est en fait une étude primaire afin 1) d’établir si le mannitol et le salin 
hypertonique sont utiles pour la réduction de la PIC de façon significative en pédiatrie 2) 
d’établir quel agent réduit de façon plus significative (supériorité) la pression 
intracrânienne 3) de préparer des études futures en pédiatrie sur la réduction à plus long 
terme de la PIC avec les agents hyperosmolaires 4) évaluer  l’impact clinique (mortalité) 
et le devenir neurologique de ces patients 5) tenter de faire des recommandations 
pédiatriques sur l’utilisation de ces agents hyperosmolaires. 
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1.6 Les risques liés à la sécurité de ceux qui participent à l’essai  
Les risques reliés à la sécurité de ceux qui participent à l’essai sont très faibles. En effet, 
ils reçoivent le même traitement standard que tous les autres patients ayant la même 
pathologie et qui ne sont pas dans l’étude. Cependant, il est fréquent que ces patients 
reçoivent à la fois du salin hypertonique et du mannitol au cours d’une même 
hospitalisation, si la réponse ne satisfait pas le clinicien ou s’il y a un changement de 
médecin traitant. C’est pour cette raison que nous avons décidé  de limiter l’étude à une 
période de quatre heures seulement, afin de ne pas limiter les patients à un seul des deux 
agents hyperosmolaires pour une période prolongée, ne sachant pas s’il y avait un 
bénéfice à alterner ou à additionner les agents ensemble. 
 
2. L'ESSAI PROPOSE 
2.1 La méthode d'expérimentation proposée 
Le devis de l’étude proposé en est un de supériorité. C sera une étude multicentrique, 
randomisée contrôlée à double insu comparant des doses équimolaires de salin 
hypertonique 3% au mannitol 20% dans la réduction de la PIC chez l’enfant avec TCC 
sévère.  
Notre critère d’évaluation primaire sera le changement de la PIC (Δ) dans les deux heures 
après chaque traitement; soit salin hypertonique ou mannitol. Nos critères d’évalation 
secondaires seront les effets adverses de ces traitements, soient; hypotension, 
hypernatrémie, IRA, une osmolarité sanguine élevée, de même que les co-interventions 
nécessaires pour diminuer l’HTIC et le changement de pression intracrânienne soutenu 
après 4h. 
  
2.2 Description des interventions prévues en cours d'essai 
Nous avons choisi de comparer deux traitements couramment utilisés dans la prise en 
charge de l’HTIC de l’enfant. Les patients seront randomisés dans deux bras : mannitol 
20% ou salin hypertonique 3%. Il n’y a pas de groupe contrôle avec placebo puisque les 
deux agents sont considérés comme un standard de traitement dans la prise en charge de 
l’HTIC chez l’enfant avec TCC sévère. 
 
Dépistage et Inclusion 
Le dépistage des patients aura lieu lors de leur arrivée au centre tertiaire avec TCC 
sévère. Après l’évaluation par les soins intensifs et la neurochirurgie, le patient sera 
considéré pour l´étude s’il y a installation de monitoring de la PIC en salle d’opération. Si 
les critères d’inclusions sont présents, le personnel de recherche sera appelé et fera le 
consentement de l’étude avec les parents, après le consentement de la pose de moniteur 
de PIC. Si les parents ne sont pas présents, ils pourront être rejoints par téléphone afin 
d’obtenir un pré-consentement qu’ils pourront signer à leur arrivée à l’hôpital.  
 
Prise en Charge 
À l’admission aux soins intensifs, après l’installation du moniteur de PIC, la prise en 
charge se fera de façon standard suivant l’algorithme décisionnel aidant à la prise en 
charge de TCC. Cet algorithme sera inclus dans le dossier du patient et guidera l’équipe 
traitante quand aux thérapies envisagées. L’objectif d’inclure cet algorithme dans le 
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protocole de recherche vise la standardisation de la thérapie pour la prise en charge de ces 
patients (Voir Annexe 1). Tout patient sera intubé et ventilé, avec sédation et analgésie en 
perfusion continue. La température sera contrôlée pour éviter l’hyperthermie, et des 
agents vasoactifs seront utilisés pour maintenir une pression moyenne adéquate. 
 
Monitoring et Surveillance 
Les signes vitaux (pris en continu) seront enregistrés aux 15 minutes pendant les 2h après 
le traitement, incluant fréquence cardiaque, la tension artérielle (TA), la fréquence 
respiratoire et la température. Le score de Glascow sera évalué et noté aux heures. La PIC 
et la pression de perfusion cérébrale (PPC) seront aussi notées aux 15 minutes dans les 2h 
suivant le traitement, et aux 30 minutes jusqu’à 4h post traitement. La diurèse sera notée 




Chaque patient avec une PIC élevée (>20mmHG) soutenue pendant plus de cinq minutes, 
ou chez qui le médecin traitant juge qu’un agent hyperosmolaire est indiqué, recevra 
mannitol ou salin hypertonique selon son allocation. L’allocation sera faite par le 
pharmacien selon la liste de randomisation qui lui aura été confiée. 
Les doses d’agents hyperosmolaires seront équimolaires, donc la même charge d’osmoles 
sera livrée à chaque patient, soit 3 Osm/kg. Le volume de salin 3% ayant une osmolarité 
un peu plus petite (1027 Osm/L vs 1100 Osm/L pour le mannitol) le volume sera 
complété avec une très petite quantité d’eau stérile pour que les deux solutions aient le 
même volume et osmolarité. Chaque agent sera préparé de façon confidentielle par la 
pharmacie et livré en seringue opaque avec tubulure opaque, identifié «agent 
hyperosmolaire».  
Le médecin et le personnel soignant seront aveugles quand à l’agent en cours. Tout autre 
traitement jugé nécessaire devrait être identique dans les deux groupes. Si le médecin 
traitant initie une thérapie pour la prise en charge de l’HTIC durant les 2h post traitement, 
ceux-ci seront considérés comme des co-interventions (coma barbiturique, hypothermie, 
hyperventilation). La diminution de la pression intracrânienne moyenne, calculée par une 
moyenne des PIC prises aux 15 minutes, sera évaluée après chaque agent pendant une 
période de 2 et 4 heures. L’intervention sera limitée au premier agent hyperosmolaire 
reçu par chaque patient. 
 
2.3 Les dispositions pratiques prévues pour la répartition des participants 
Les participants seront randomisés dans chaque groupe, soit mannitol ou salin 
hypertonique avec une allocation 1 :1. Nous utiliserons une randomisation générée par 
ordinateur par notre statisticien, par blocs de 2 et de 4, stratifiée par centre. Le logiciel R 
sera utilisé pour la randomisation avec une semence (seed) spécifique pour assurer la 
reproductibilité de la liste de randomisation. Quatre centres sont prévus; deux centres 
auront un recrutement prévu de 4-5 patients par an et 2 centres de 7-8 patients par an. La 
randomisation sera gardée confidentielle par le statisticien du projet et des listes de 
chiffres pour randomisation seront envoyées aux pharmacies de chaque centre. 
L’éligibilité du patient et le consentement devront être effectués avant l’allocation du 
groupe assigné. 
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2.4 Les méthodes proposées pour éviter qu'il y ait des sources de biais 
Les patients seront randomisés avec un système confidentiel tel que mentionné dans le 
paragraphe précédent. La pharmacie préparera pas la suite les solutions, à volume égaux 
dans des seringues opaques avec tubulures opaques. Malgré le fait que les deux solutions 
sont transparentes, le mannitol peut parfois avoir des micro-dépôts de sucre qui rendent la 
solution légèrement opaque. Il sera donc impossible d’identifier la solution au chevet du 
patient. L’infirmière au chevet, le médecin traitant, l’infirmière de recherche et la 
personne qui gère la base de données seront aveugles. De plus, l’issue primaire est une 
mesure objective et toutes co-interventions seront prises en compte. 
Il se pourrait par contre que des patients soient randomisés mais ne reçoivent jamais 
l’intervention en question si leur PIC ne s’élève pas. Ceci engendrerait un biais non-
différentiel puisque l’étude est randomisée et cet effet devrait se retrouver également dans 
chaque groupe, ce qui sera pris en compte dans notre calcul de taille d’échantillon. 
L’analyse se fera par Intention de traiter et par intention de traiter modifiée pour évaluer 
ces différences. 
 
2.5 Les critères d'inclusion et d'exclusion prévus 
Éligibilité : Le dépistage des patients se fera par l’équipe neurochirurgicale et/ou les soins 
intensifs, lors de l’évaluation du TCC sévère et de la mise en place d’un moniteur de PIC. 
L’infirmière de recherche sera ensuite contactée pour faire le consentement. Durant les 
heures non-ouvrables, un médecin de garde sera désigné au consentement du patient.  
Inclusion : Tout patient de plus de 1 mois et moins de 18 ans, avec critères de TCC 
sévère (Glasgow < ou = 8), et mise en place de moniteur de PIC par la neurochirurgie, 
seront éligibles.  
Exclusion : 1) tout patient avec mort cérébrale ou état moribond, 2) patients subissant une 
craniotomie décompressive 3) grossesse 4) hypernatrémie avec Na > 155 mosm/L 
(relative contre-indication salin 3%) 5) Osmolarité > 320mOsm/L (contre-indication 
mannitol) 6) Insuffisance rénale aigue sévère (contre-indication relative mannitol). 
 
2.6 La durée prévue de la période de traitement 
Les patients seront recrutés et randomisés dans les 48h suivant leur TCC. Une fois la 
décision d’administrer un agent hyperosmolaire après l’inclusion, le traitement sera 
donné en 20 minutes et le suivi de la pression intracrânienne se poursuivra pendant 4h 
post traitement. 
 
2.7 La durée et la fréquence prévues du suivi 
Les signes vitaux (FC, TA, diurèse) des patients seront recueillis aux 15 minutes pendant 
les deux heures après un agent hyperosmolaire, puis au 30 minutes jusqu’à quatre heures 
post agent hyperosmolaire. La PIC et la PPC seront récupérées directement du moniteur 
aux 5 secondes. Des bilans sanguins pour évaluer les électrolytes et la glycémie seront 
effectués à T240. 
 
2.8 Les méthodes principales et secondaires proposées pour la mesure des résultats 
Évènement principal étudié 
Geneviève'Morissette' ' The'HOT'PEABRAIN'Trial'Nadia'Roumeliotis' ' '
' 6'
L’évènement principal étudié sera la baisse de la pression intracrânienne entre les deux 
agents. Cette mesure se fait avec un moniteur de la pression intracrânienne en continu 
aux soins intensifs. Cette mesure étant continue et variable dans le temps, une moyenne 
des PIC notées aux 5 secondes sera calculée (T0 à T 120) et comparée à la PIC moyenne 
dans les 5 minutes avant d’initier le traitement hyperosmolaire (T-5 à T0) 
Autres variable d’intérêt 
Un calcul de la durée de la période où la PIC sera inférieure à 20 mmHg sera aussi 
effectuée afin d’évaluer de façon plus approfondie l’impact clinique futur de ces 
thérapies. Nous mesurerons aussi la pression de perfusion cérébrale (CPP), qui est la 
différence entre la tension artérielle moyenne (TA) et la PIC. Les complications des 
traitements : hypotension, hypovolémie et diurèse seront notées par l’infirmière dans le 
suivi pendant les 4h post traitement. L’hypernatrémie, la glycémie et l’acidose 
métabolique seront évaluées avec les prélèvements à T240. 
 
2.9 De quelle façon la mesure des résultats se fera-t-elle lors du suivi ?  
Dans les unités avec saisies de données électroniques, les valeurs de signes vitaux seront 
saisies automatiquement, puis rentrées dans une base de données par l’infirmière de 
recherche par la suite. Dans les centres où les données ne sont pas informatisées, 
l’infirmière de chevet sera chargée d’écrire les signes vitaux aux 15 minutes après 
l’intervention aux temps indiqués (tel que se fait de façon relativement standard aux 
heures dans les unités de soins intensifs). Une infirmière de recherche fera la saisie de 
données dans la base de données sur Acces par la suite. 
 
2.10  L’essai englobera-t-il des sujets de recherche sur les services de santé ? 
Ne s’applique pas 
 
2.11 Taille proposée de l’échantillon  
L’étude de Francony et al. démontre une baisse de la PIC de 45% +/- 19% pour le groupe 
mannitol et de 25% +/- 14% dans le groupe salin hypertonique7. Celle de Battison et al.  
rapporte une baisse de 59% avec le salin et de 31% avec le mannitol (12). Cliniquement, 
une baisse de la PIC de 5 mmHg est significative car il est bien reconnu que les 
dommages cérébraux sont significatifs lorsque la PIC reste de façon soutenue > 20 
mmHg et sont plus importants > 25mmHg15. Selon cette littérature, il semble qu’une 
différence de 20% de la PIC soit cliniquement significative. Le calcul de la taille 
d’échantillon s’est fait en utilisant un t-test pour comparer 2 moyennes indépendantes. 
Les résultats de l’étude de Francony et al ont été utilisés comme moyenne pour chaque 
groupe ainsi que leur déviation standard afin de calculer un «effect size» de 1,198443. Un 
alpha à 0,05 et une puissance de 0,9 ont été utilisés. Il devra y avoir 13 patients par 
groupe, soit un total de 26 patients. Nous estimons, à la lumière d’une étude rétrospective 
dans notre centre que 20% des patients recrutés ne recevront pas d’agents 
hyperosmolaires et donc l’ajustement est fait pour 20% de plus, soit 26/0.8= 32,5 
patients. Un nombre de 34 patients a été retenu pour être conservateur. 
 
2.12 Quel est le taux de recrutement prévu ?  
Nous savons qu’il y a actuellement 4-5 TCC pédiatriques sévères/année au CHU Sainte-
Justine et au Montreal Children`s Hospital nécessitant une pose de PIC. À l’hopital 
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Sacré-Cœur et au Montreal General Hospital, deux centres adultes, ils comptent environ 
7-8 TCC adolescents par années, pour un total des 4 centres d’environ 20 en étant 
conservateur. Compte tenu que nous voulons recruter 34 patients, nous devons prévoir 
une période de recrutement de 2 ans, en assumant qu’environ 85% des parents 
accepteront d’inclure leur enfant dans l’étude ((20 x 2) x0,85= 34). 
 
2.13 Est-il probable qu'il y ait des problèmes d'inobservation ? 
L’inobservance dans cet essai est peu probable puisque nous avons écourté la période 
d’observation à quatre heures seulement, dans le but de permettre aux cliniciens d’être à 
l’aise avec ce protocole. En effet, dans la réalité, les deux agents hyperosmolaires sont 
souvent administrés au même patient mais pas dans une courte période. De cette façon, 
les habitudes des cliniciens ne seront pas trop modifiées.  
 
2.14 Quel est le taux probable de réduction de l'échantillon pendant le suivi ?  
Comme il s’agit de patients aux soins intensifs et gravement malades observés sur une 
courte période de temps, il y a peu de chances de perdus de vue. En effet, il pourrait y 
avoir un certain nombre de décès, mais ceux-ci surviennent généralement plus tard que 
dans la courte fenêtre utilisée. 
2.15 Le nombre de centres participant à l'essai 
Les quatre centres inclus sont les centres principaux pour la prise en charge 
neurochirugicale du trauma crânien de l’enfant au Québec. Tous se situent dans la ville 
de Montréal. Deux centres sont désignés pédiatriques et les deux autres sont des centres 
adultes de traumatologie qui incluent des adolescents < 18 ans dans leur clientèle.  
 
2.16 Quel est le type d’analyse proposé ? 
Les données seront entrées dans la base de données par les infirmières de recherche et 
validées par les chercheurs principaux. Par la suite, un statisticien indépendant fera les 
analyses à l’aide du logiciel SPSS version 21.  
Les analyses concernant l’issue primaire et les issues secondaires seront d’abord 
effectuées selon l’intention de traiter (ITT). Cependant, si le nombre de patients inclus 
qui n’ont pas reçu de traitement est plus important que celui prédit (20%), nous devrons 
faire des analyses en intention de traiter modifiée. Un niveau alpha de 5% sera utilisé 
comme seuil de significativité pour toutes les analyses. D’abord, les caractéristiques de 
base (âge, genre, poids, osmolarité sanguine  et natrémie avant et après traitement, PIC à 
l’installation du moniteur, PIC avant le traitement hyperosmolaire, durée séjour 
hospitalier, durée séjour aux soins intensifs, mortalité) dans les 2 groupes seront 
comparées à l’aide du test t pour échantillon indépendants, ou du Mann Whitney pour les 
variables continues, et du Khi-2 de Pearson pour les variables catégorielles. Par la suite, 
l’issu primaire sera mesurée par la différence entre la PIC avant le traitement et la 
moyenne de PIC dans les deux heures suivant le traitement (∆ PIC) en pourcentage (∆ 
PIC/Pic initiale). Il sera calculé pour chaque patient et les résultats seront comparés à 
l’aide du test t pour échantillons indépendants si la distribution est normale ou Mann 
Whitney si elle ne l’est pas. Pour les issus secondaires, le même calcul sera fait avec les 
données dans les 4 heures suivant le traitement. Ce même calcul sera aussi fait pour la 
pression de perfusion cérébrale. Finalement, il y a aura une comparaison entre les effets 
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secondaires mais le nombre de patients étant limitées, ces analyses n’auront pas beaucoup 
de valeur autre que de faire ressortir un effet secondaire très fréquent. 
2.17 Quelle fréquence est proposée pour les analyses ? 
Comme il s’agit d’une étude pilote avec un petit nombre de patients, nous ne ferons pas 
d’analyse intérimaire. Toutes les analyses seront faites à la fin de l’étude. 
2.18 Est-il prévu de faire des analyses de sous-groupes ? 
Chaque analyse sera stratifiée par centre. Cependant, il n’y aura pas d’analyse de sous-
groupe car le nombre de participants est assez petit ce qui ne nous permettrait pas d’avoir 
une bonne puissance statistique. 
2.19 Des études pilotes recourant à la même méthodologie ont-elles été menées ? 
Pour le moment il n’y a aucune étude pédiatrique qui a utilisé la même méthodologie. 
Cette étude sera en quelque sorte l’étude pilote qui nous permettra, selon les résultats, de 
monter un devis différent afin d’évaluer l’efficacité clinique au long cours de l’un ou 
l’autre des ces agents hyperosmolaires. 
 
3.'GESTION DE L'ESSAI 
3.1 Quelles dispositions sont prévues pour la gestion quotidienne de l’essai ? 
L’investigateur principal et le co-investiguateur, ainsi que le centre coordinateur le CHU 
Sainte-Justine, seront responsables de la gestion de l’étude. La gestion de la base de 
données sera effectuée par le CHU-Sainte Justine. 
Une infirmière de recherche dans chaque site sera disponible sur appel pour discuter avec 
les parents et faire signer le consentement pendant la journée. Comme il y a peu de cas de 
traumatisme crânien sévère dans chaque centre, nous ne pouvons pas nous permettre de 
recruter seulement les jours de semaine. Chaque infirmière aura donc une semaine de 
garde/mois où elle devra être disponible pour venir faire le consentement la nuit ou la fin 
de semaine au besoin si le médecin de service est trop occupé pour le faire. Elle sera de 
garde pour les quatre centres et recevra une rémunération pour être de garde et un bonus 
pour chaque déplacement effectué. Elles seront aussi responsables de recueillir toutes les 
données pendant les 4 heures après le bolus et de les mettre dans la base de données 
Acces qui sera conservée sur un serveur sécurisé.  
Le pharmacien de chaque site s’occupera de la préparation de la médication. Pendant la 
nuit, les pharmaciens de garde recevront un forfait  spécial s’ils doivent se déplacer pour 
l’étude seulement.  
 
 
3.2 Le rôle de chacun des candidats et co-candidats proposés 
Dre Roumeliotis et Dre Morissette seront responsables de la gestion de la recherche au 
jour le jour. Elles seront aussi en charge de l’interprétation des résultats de l’étude et de la 
rédaction du/des articles. Il y aura un responsable de la coordination dans chaque site qui 
sera choisi parmi les médecins ayant un intérêt spécifique pour le TCC et la recherche 
aux soins intensifs. Le statisticien sera responsable de l’analyse statistique des données 
intérimaires et finales de l’étude 
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3.3 Description du comité de direction et du comité de surveillance et de protection 
des données 
Le comité de direction sera constitué de 4 experts en soins intensifs, soit 2 en médecine 
adulte et 2 en pédiatrie. Il y aura un neurochirurgien, un pharmacien et un expert en 
analyse statistique et méthodologie. 
Le comité de surveillance sera constitué de 4 experts en soins intensifs, soit 2 en 
médecine adulte et 2 en pédiatrie. Il y aura un neurochirurgien, un pharmacien et un 
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